Advertisements


Personnel changes: North Texas tech and startup execs made moves in February

Meet the leaders who entered and left the DFW tech and startup scene in February......»»

Category: topSource: bizjournalsFeb 26th, 2021

Orlando is gearing up to become a rival to Silicon Valley - and shift away from being a destination primarily for tourists and retirees

Lockheed Martin, Oracle, Verizon, and Deloitte all have offices in Orlando - and more companies are joining them. Orlando has talent, transport, and low taxes. John Greim/Loop Images/Universal Images Group via Getty Images Orlando has been shaking off Florida's reputation as primarily a place for tourists and retirees. Instead, the city is becoming a hub for tech, defense, training, and finance companies. Execs from EA, Luminar, and Stax told Insider why its tech scene is thriving. See more stories on Insider's business page. Defense and technology startup Red 6 is opening a hub in Orlando to develop its airborne tactical augmented reality system.It's one in a long line of companies, including Lockheed Martin, Oracle, Verizon, and Deloitte, with offices in the central Florida city.For years, people have viewed the Sunshine State as primarily a vacation and a retiree destination, but groups such as the Orlando Economic Partnership have been working to elevate its profile as a tech hub."In Orlando, everyone knows the Disney story," Tim Giuliani, the Partnership's president, told Insider. "This part of the story that people don't know or don't recall is the space race."NASA started performing launch operations in Cape Canaveral more than 70 years ago. The city is also home to the Kennedy Space Center and US Army, Air Force, and Navy simulation command centers, which has led to an influx of other technology, defense, and training companies."You have this cluster here, that's developed over a long time, and now you're seeing it get to a critical mass," Giuliani said. "You're seeing more companies moving out of California and New York.""We've made great strides in growing our reputation as a city where tech companies and start-ups can not only open, expand, relocate, and thrive, but be in proximity to some of the world's leaders in innovation," Orlando Mayor Buddy Dyer added.Orlando has talent, transport, and low taxesExecs from Electronic Arts, Luminar, and Stax told Insider that Orlando's big talent pool made it easier for them to recruit in the area."We have all these great colleges that are literally in our backyard," Suneera Madhani, founder of Orlando-based SME payments platform Stax, said. These include the University of Central Florida, the University of Florida, and Valancia College.Giuliani said there were half a million college students within a hundred-mile radius of downtown Orlando."We have been able to tap into that talent," Luminar CTO Jason Eichenholz said. The self-driving LIDAR startup has around 400 employees, with roughly 60% based in Orlando."In the early days of Luminar, when we would meet with a potential customer and they'd have one specific LIDAR engineer, we would have a millennia of men and women, experienced in LIDAR technology, which gave us a very unfair advantage compared to our competition," Eichenholz added.The execs said it was easy to recruit workers from other states to move to Orlando, too.Electronic Arts vice-president Daryl Holt said its Orlando studios had more than 850 employees - some from the area, including many UCF graduates, and some who relocated.Migration to the state has boomed because of its warm climate, low living costs, and lack of income tax."Who wouldn't want to move to Florida?" Mahdani said. Many of Stax's C-suites and middle management relocated from New York, California, and Atlanta, he added.Eichenholz said some young tech workers relocated to California to work for companies like Google, Apple, and Facebook, but that once they had a family, "we do exceptionally well in being able to attract them back to Florida."The execs said Orlando had a pro-business environment and bustling tech community. Madhani, for example, sits on the board of Starter Studio, a venture-tech accelerator that helped her set up Stax in 2014."It's a wonderful nexus point of industry, education, and government all rowing in the same direction," Holt said.Giuliani said Orlando is a well-connected city. As well as an international airport, Brightline is due to launch a rail line connecting Orlando to Miami, Fort Lauderdale, and West Palm Beach in 2022."Obviously Silicon Valley is not going to die and New York's not going to die," Giuliani said. "There's just going to be more for everybody else."Read the original article on Business Insider.....»»

Category: worldSource: nyt20 hr. 42 min. ago

How technology is changing the advertising industry

The crackdown on ad tracking and changing consumer habits are upending how advertisers market and target consumers. Here's a breakdown. Toby Melville/Reuters Technology has upended the advertising business. Ad tracking and consumer habit changes are impacting how advertisers reach people and fueling new companies. Here's a breakdown of Insider's coverage of how ad buyers and sellers are impacted. See more stories on Insider's business page. The advertising industry is going through big changes as technology changes upend consumer habits and where and how marketers reach them.Apple and Google's phasing out third-party cookies threatens to upend longstanding ad targeting practices. The acceleration of streaming TV has fueled the chase for TV ad dollars. The move away from cookies and rise in online shopping has fueled new agencies specializing in digital advertising and led to a flurry of deals and investment in ad tech companies. Insider has been tracking these trends at some of the biggest advertising buyers and sellers, including WPP, Omnicom, Google, and Amazon, and rounded up our coverage.The crackdown on ad tracking is changing advertisingTargeting changes are forcing advertisers to come up with new ways to reach consumers. Google and Apple have sent shockwaves through the ad industry when they announced changes that would put an end to longstanding ad targeting practices in the face of pro-privacy regulation.Those moves have led marketers, their agencies, and adtech companies like LiveRamp and The Trade Desk scrambling to find workarounds.Read more: Google's move away from targeted advertising threatens to upend marketers' scramble to save digital ads Apple's recent privacy changes are already wreaking havoc on Facebook advertisers, and ad buyers are scrambling to manage the disruptionsAd giant Dentsu is going through a massive culling of its agencies - here's what we know about the winners and losers The ad industry is looking for a way to save targeted ads, but publishers worry it'll cheapen their reader relationships and cost them revenueMarketing meets tech Employees work at the chocolate maker Mars Chocolate France plant in Haguenau. Vincent Kessler/Reuters Companies are finding new ways to zap ads at people by building homegrown tools, using targeted ads, or ​​snapping up ad tech and martech companies.Brands like Anheuser-Busch, Mars, P&G and L'Oréal have ramped up efforts to gather data on consumers as platforms clamp down on ad targeting and e-commerce accelerates.Read more:The owner of MacWorld and InfoWorld is buying a tech firm to survive the death of third-party cookies, and is plotting even more acquisitionsMeet 19 execs at companies like Adobe and Shopify who are shaping the future of marketing techAnheuser-Busch InBev has amassed data on 2.5 billion consumers and is using it to get around new ad targeting challenges, growing sales as much as 80% Candy maker Mars built a tool that tracks people's emotional reactions to ads, and says it's lifting sales by as much as 18%Big brands like Nike and Neiman Marcus are snapping up tech companies to learn more about their customers as old ways of ad targeting go away21 advertising execs who are finding new ways to target people in a privacy-centric worldOnline fashion marketplace Farfetch is doubling down on 'addressable' TV ads as competition intensifies with Amazon for luxury shoppersAdtech is hot againEven as advertisers slashed their spending in the economic downturn, the rise of streaming TV and online shopping has benefitted adtech companies that help connect ad buyers and sellers and solve advertising and marketing problems.Investors are pouring money into firms like like TVision DoubleVerify that are solving problems in digital advertising. Other firms are going public as Wall Street fell back in love with adtech due to broad macroeconomic changes. Email marketing is getting new attention as reliable way to target compared to digital advertising.Read more:A startup that wants to bring a 'Moneyball' approach to ads raised $8 million from investors like Stage 2 Capital and SamsungIntuit's $12 billion deal to buy Mailchimp could kick off a wave of email M&A. Here's who insiders think will be the new buyers, and who they'll be targeting.TV ratings giant Nielsen has lost the media industry's backing. These 6 companies could replace it.9 hot European digital-marketing companies that experts say are prime acquisition targets in 2021The Trade Desk is taking on Google for digital ad dollars, and the battle is about to get more complicated9 adtech companies that advertisers are flocking to for new ways to zap ads at people and measure whether they work The 18 hottest adtech companies of 2020 8 of the most promising tech startups in public relations, according to investors20 experts who are working on big solutions for advertisers as ad targeting as we know it goes away Ad agencies are getting disruptedWhile the established holding companies scramble to adapt to the digital shift, new ad companies focused on digital specialities and armed with new private-equity funding threaten to take their place. Read more:12 advertising upstarts that are challenging ad giants like WPP and OmnicomDept is one of the fastest-growing advertising companies. Its CEO explains the Carlyle-backed firm's plan to become the leading digital agency.13 power players at S4 Capital helping Sir Martin Sorrell build a digital challenger to ad giant WPPAd agencies that are top acquisition targets as private equity money pours inExperts name 12 companies that are likely acquisition targets as online shopping takes offRetailers are seeking a piece of the ad pie Instacart is adding 30-minute delivery. Instacart A new set of companies sees an opportunity in selling advertising include food delivery companies, online retailers, and brick-and-mortar grocers. They're hoping to replicate the success of Amazon, which claimed 10.3% of the US digital ad market in 2020 and is competing with Google and Facebook for ad budgets.Advertising is Amazon's fastest-growing business and brought in $21 billion in 2020. Here are the 21 top insiders leading the charge.Alan Moss is spearheading Amazon's push to steal ad dollars from Facebook and Google. Insiders lay out his playbook for getting a slice of the $70 billion TV ad market.Uber just hired a top Amazon advertising exec. Here are 45 other big hires that show how it and other companies are warring for advertising dollarsAmazon, Walmart, and Instacart are vying for advertising dollars - here's exactly how much they charge for ads18 firms that are helping solve marketers' giant problems selling and advertising on AmazonExperts lay out how Instacart, Walmart, and other retail ad sellers can take on Amazon in digital advertising Read the original article on Business Insider.....»»

Category: topSource: businessinsiderSep 24th, 2021

Kraft Heinz has cut costs to the bone. Insiders say the strategy has hurt innovation, created employee turnover, and more.

Kraft Heinz has been cutting costs across the board - and here's why critics say one of the biggest names in food has taken several steps back. Jell-O, Heinz ketchup, and Oscar Mayer hot dogs are among Kraft Heinz's best-known products. Kraft Heinz; Shutterstock; Marianne Ayala/Insider Kraft Heinz has gotten a sales lift from pandemic demand for food that people can eat at home. But the company has suffered under the private-equity owner 3G Capital since its 2015 creation. Here's a rundown of why critics say one of the biggest names in food has taken several steps back. See more stories on Insider's business page. Kraft Heinz owns some of the best-known brands in food, including Jell-O and Oscar Mayer hot dogs.But people familiar with the company's strategy say it's mismanaged them by focusing too much on maximizing profits instead of building up the business.Insiders also say Kraft Heinz and its private-equity owner, 3G Capital, have failed to invest enough in new products that would grow sales over the long haul.And while demand for more food Americans can eat at home has lifted Kraft Heinz's sales during the coronavirus pandemic, employees still left en masse this year, anticipating more problems after things return to normal.The danger for Kraft Heinz now is that while it has massive scale advantages over upstart brands like Beyond Meat, Hu chocolate, and Flow water, selling products under decades-old brands may become more complicated. Many consumers are looking for new and healthier options. If the company focuses too much on efficiencies, Kraft Heinz risks missing out on the next big food trend, according to food-industry analysts.Below is Insider's coverage of the fallout at Kraft Heinz resulting from the company's cost-cutting strategy:Kraft Heinz budget cuts created a dysfunctional companySince its 2015 inception, following the $50 billion merger of Kraft Foods and H.J. Heinz, Kraft Heinz has cut costs under a model that 3G Capital used to make operations leaner at Burger King and Tim Horton's.Kraft executives have told investors they would run the company more efficiently while finding new ways to grow sales. Attempts at the latter included selling blended versions of the company's condiments, which led to the release of a mix of its ketchup and ranch known as "Kranch."At the company's corporate offices, employees are feeling the squeeze of that strategy. Budgets for everything from travel to promoting new products were cut year after year. The company also went through annual reorganizations and rounds of layoffs, with those left behind forced to do more with less.Read more: 3G's merger of Kraft and Heinz is killing morale, causing burnout, and choking innovation, some employees say. Now, the company could get left behind as the economy reopens.Read more: Why the private-equity playbook failed Kraft HeinzRead more: Kraft Heinz just agreed to sell Planters for $3.4 billion. Here's how the deal fits into its broader culling of food brands.Read more: Kraft Heinz just unveiled a 'platform'-based strategy for managing its food brands. Here's how the top US executive hopes to finally get sales growing again. Kraft Heinz; Samantha Lee/Insider Kraft Heinz's investments in e-commerce may not be enough in the long runKraft Heinz has championed some high-growth areas of its business. The best example is its e-commerce division, which manages relationships with online retailers like Amazon. Kraft Heinz even tapped a 15-year veteran of Amazon as its most recent e-commerce chief.But even that part of the business has been beset by problems. Employees say recruits from the tech world have clashed with old-school food-industry employees, leading to turnover. In September, a leaked email revealed the company's e-commerce lead was headed out the door.Industry analysts also say investing in areas like e-commerce, even if done right, may not be enough to prop up the company.Read more: Kraft Heinz tried to supercharge its e-commerce strategy by looking to Amazon. Instead, it created 'a clash of cultures' between the old-school food industry and tech types.Read more: Leaked email reveals Kraft Heinz is losing its e-commerce chief, an Amazon hire who created 'a clash of cultures' between the old-school food industry and tech typesRead more: Experts say Kraft Heinz faces a real nightmare scenarioKraft Heinz is an extreme example, but other big food companies also face challenges as they try to stay relevantBig food companies have scale, but they aren't always nimble enough to respond to consumer demands. Kraft Heinz and its peers, including Kellogg, General Mills, Unilever, and Nestlé, have set up initiatives to work with small brands to stay on top of trends.Like Kraft Heinz, many have also benefited from an eating-at-home craze during the pandemic. As vaccines become more widespread and daily life moves toward normal, those companies are trying to keep as many of those pandemic-era customers buying as possible.Read more: CPG giants like Procter & Gamble and Mars are on the hunt for the next DTC breakout company. Here's what 4 execs say they're looking for.Read more: Shoppers flocked to packaged foods during the pandemic. Now, Kraft Heinz, General Mills, and Kellogg are supercharging marketing spend to keep them buying.Read more: Here's how to impress a VC with your food startup, according to the head of Kraft Heinz's $100 million venture fundRead the original article on Business Insider.....»»

Category: personnelSource: nytSep 21st, 2021

Strong Start Ruined as Rally Falls Apart

Strong Start Ruined as Rally Falls Apart Each of the major indices were up by more than 1% at their highest points of Monday’s session. However, the end result was very different as that rally was spoiled by a late-session selloff that not even technology could save. In fact, the tech sector led the move lower, sending the NASDAQ to the worst performance of the day by far. The index, which has been surprising investors with its resilience in the face of rising coronavirus cases, plunged 2.13% (or about 226 points) to 10,390.84. It had been up by nearly 2% earlier in the day. The S&P briefly moved onto positive ground for the year after rising by 1%, but it too faltered and finished lower by 0.94% to 3155.22. The Dow managed to stay in positive territory… but let’s not get too excited. The index soared by 2.2% (or over 500 points) at the high point, but it finished in the green by only 0.04% (or about 10 points) to 26,085.80. The market has been largely ignoring the rise in cases of late, so it wasn’t much of a surprise that the day started so strongly despite another rough weekend. Florida was especially hit hard. Plus, we enjoyed some good news on the vaccine front as two of the candidates from Pfizer/BioNTech were granted fast track designation. But it wasn’t to last, and news that California was closing indoor operations again just exacerbated the reversal. This delay in reopening is exactly what the market doesn’t want to hear, because it means a delay in the economic recovery as well. That’s a rough start to the week, especially with stocks on a roll after back-to-back weeks with all major indices moving upward. Has the market moved as high as it can in this perilous environment without good news on cases or reopenings? Or is this just another one or two-day pullback? Let’s see where the rest of this week takes us. And don’t forget that the beginning of earnings season is upon us with JPMorgan (JPM), Citigroup (C) and Wells Fargo (WFC) all reporting tomorrow. Today's Portfolio Highlights: Counterstrike: This crazy forward momentum is rewarding investors who chase stocks, and Jeremy isn’t going to fight the trend even though it’s not really his style. On Monday, he added Turtle Beach (HEAR), an audio technology company that beat by 69% in May and then raised its guidance in June. The editor thinks this stock could soar about 30% from here to more than $23. Meanwhile, in the first post-earnings buy of the quarter, the portfolio also added Greenbriar Companies (GBX). This supplier of transportation equipment to railroads beat the Zacks Consensus Estimate by 452% last week while revenue also crushed expectations. Jeremy thinks this name could jump about 25% from here, so he’ll be buying more on any dips. HEAR and GBX are both Zacks Rank #1s (Strong Buys) that were added with 5% allocations. The portfolio also sold half of (DPZ) for an 8.4% return. Read the full write-up for more on today’s moves. By the way, the ProShares UltraPro Short QQQ (SQQQ) position was one of the best performers today with a gain of 6.15%.  Surprise Trader: With earnings season about to kick off, be prepared for A LOT of new additions to this portfolio in the coming weeks. Dave got things started on Monday by buying Bancorp South Bank (BXS), a regional bank in the Southeast. The editor sees tons of opportunity in regional banks, which have lagged so far this year. However, the editor agrees with analysts that a migration from large cities in the north to towns in the south will be a big benefit for that part of the country and its banks. BXS has beaten expectations for three straight quarters now, including a healthy surprise of more than 43% last time. It has a Positive Earnings ESP of 1.09% for the quarter coming after the bell next Monday, July 20. The portfolio added BXS on Monday with a 12.5% allocation, while also selling MSC Industrial (MSM). Technology Innovators: The past two quarters have seen big beats for US Cellular (USM) and Brian likes its valuation at the moment. Perhaps most importantly, rising earnings estimates for this year and next have made this wireless carrier a Zacks Rank #1 (Strong Buy). Therefore, the editor added USM on Monday. Black Box Trader: The portfolio refreshed half of its positions in this week's adjustment. The stocks that left the portfolio today included: • Patterson Cos. (PDCO, +1.7%) • Lakeland Industries (LAKE, +0.9%) • Lowes Cos. (LOW) • LPL Financial (LPLA) • WillScot (WSC) The new buys that filled these open spots were: • Deutsche Bank (DB) • Nautilus Group (NLS) • PulteGroup (PHM) • Sally Beauty (SBH) • Vista Outdoor (VSTO) Read the Black Box Trader’s Guide to learn more about this computer-driven service designed to take the emotion out of investing. Until Tomorrow, Jim Giaquinto Recommendations from Zacks' Private Portfolios: Believe it or not, this article is not available on the Zacks.com website. The commentary is a partial overview of the daily activity from Zacks' private recommendation services. If you would like to follow our Buy and Sell signals in real time, we've made a special arrangement for readers of this website. Starting today you can see all the recommendations from all of Zacks' portfolios absolutely free for 7 days. Our services cover everything from value stocks and momentum trades to insider buying and positive earnings surprises (which we've predicted with an astonishing 80%+ accuracy). Click here to "test drive" Zacks Ultimate for FREE >>  Zacks Investment Research.....»»

Category: topSource: zacksSep 21st, 2021

Tech Driven NASDAQ Soars Again

Tech Driven NASDAQ Soars Again Zacks Ultimate, This is Brian Bolan filing in for the Ultimate Editor Jim Giaquinto.  Jim has some incredible foresight … not into the markets per say, but just for taking the day off when the market moves in a big way.  I think I will have to start informing my readers ahead of time when Jim is taking off… the move would be to put on a straddle options trade as we don’t know which way it will go, but it will go one way in a big way! The way the market went today was up.  Up, up and away for the NASDAQ as that index posted a gain 2.5% on the day.  The Dow fought back from being in the red most of the day and closed with a small gain of about 9 points thanks to a flurry of selling near the close.  The S&P 500  was up 0.84% and saw some selling at the close, but nothing like what was seen in the Dow Jones. I wanted to make an addition in Tech Innovators today, but I was waiting for a pull back that never came. A former boss used to say if you are waiting for a pull back you are timing the market… or at least trying to and that is just what I feel like today.  I tried to time an entry when I just should have pulled the trigger.  The NASDAQ was up almost 100 points and wanted it to be up only 85 points.  Then is was up 130 points and I begged for a 30 retreat to allow me to enter.  Then it was up 165 points and I figured the ship had sailed and it might even be a good short entry.  Then we got to +200 and later +250. There is a significant tailwind for tech stocks.  The combination of unprecedented stimulus and a favorable market environment has made valuations start to inflate.  Not balloon, just inflate.  Staples are not the fad, nor are financials.  Its tech, tech and more tech. Broader Market There was plenty of talk on Twitter over the weekend about vaccine announcements.  From what I saw, you would have thought that we would get 3 or ever 4 announcements so I dragged my feet a little on my morning dog walk so I could be in front of the computer for the news.  There really wasn’t anything to write home about, so Buckeye and I had a little warmer than expected walk. That said, there have been surges in several states… but we continue to find out that there are lots of bad numbers in the system.  An Ohio man was tested 15 times, while in the hospital with COVID, and you guessed it, each time he still had it… but each time was counted as a new instance of COVID.  This could be a one off problem, but there are also tons of issues in FL as well.  The numbers we should be watching are the ICU bed rates --- how many beds are available.  The deaths are falling as some new treatments are being tested, and that is great news… but it is even better when people stop getting sick from COIVD at all. I saw on TV that the S&P was positive for the year… and that has to really burn the shorts.  A year that saw an economic shutdown and a market crash has stocks basically flat on the year.  That is amazing.  But what is the lesson?  You cannot fight the Fed… they are pouring money into the system and some of it is landing in the lap of fund managers and they are not keeping it as cash.  That is why I want to be fully invested. Advancers beat out decliners today, but only by a small measure as the tech names really skewed todays action.  Take them out of the equation and the market finishes lower.  New highs blistered to 400+ which is almost what I would consider a frothy number… but recall all the pessimism out there and how the market loves to humble the naysayers.  Portfolio Moves Jeremy Mullin is not only the head of Counter Strike but he also heads up Commodity Innovators as well. Today I see he sold VanEck Gold Miners (GDX) for a 32% gain.  He also moved to add Cleveland Cliffs (CLF) to the portfolio today. Mr. Mullin is bullish on iron ore and steel prices as he looks to a resurgence in global demand to keep those prices rising.  His gold play was a longer term hold, but he still has some other exposure to the space should the miners continue to roll higher. BlackBox Trader made a slew of moves today as it normally does on Monday. This service sold five previous positions: DR Horton Inc (DHI), Sally Beauty Holdings (SBH), PulteGroup (PHM), Deutsche Bank (DB) and Cheniere Energy (LNG). The algo selected 5 new names that were added today: Hansebrands Inc (HBI), Caesars Entertainment (CZR), Office Depot (ODP), Berry Global Corp (BERY) and Robert Half Intl (RHI). This wouldn’t be a complete write up without a little self promotion.  My mother used to say “self praise stinks” – actually, she still says this and hates when I toot my own horn.  I am more in the camp of “self praise pays” because who else in this world thinks I am as great as I think I am?  I say that with my tongue firmly implanted in my cheek. That said, Tech Innovators is crushing is, with TSLA leading the way up 291% since mid March.  I have no plans to sell this stock and I see it speeding north of $2000 in the near future.  TWOU is up 125% over the same time period and those two names sit atop my Innovators Series service.  Home Run Investor has two names posting gains of 100% or more.  The health of that portfolio is super strong with 13 of the 14 names in the green and lone red number is only -2.8%. Stocks Under $10 is my other service that has its own pair of 100%+ winners.  Expect some action in that service tomorrow as there are only 13 names out of a maximum of 15 for that service. Jim will return tomorrow with a more balanced view across all the portfolios… so be sure to sign up for the three that I manage to hear more from me. See you soon, Brian Recommendations from Zacks' Private Portfolios: Believe it or not, this article is not available on the Zacks.com website. The commentary is a partial overview of the daily activity from Zacks' private recommendation services. If you would like to follow our Buy and Sell signals in real time, we've made a special arrangement for readers of this website. Starting today you can see all the recommendations from all of Zacks' portfolios absolutely free for 7 days. Our services cover everything from value stocks and momentum trades to insider buying and positive earnings surprises (which we've predicted with an astonishing 80%+ accuracy). Click here to "test drive" Zacks Ultimate for FREE >>  Zacks Investment Research.....»»

Category: topSource: zacksSep 21st, 2021

Great Start to November with Epic Election Week Rally

Great Start to November with Epic Election Week Rally Stocks finally cooled off a bit on Friday after four straight days of sharp gains, but it didn’t make a dent in one of the strongest weekly performances of the year. The NASDAQ soared 9% in these five days, while the S&P was up about 7.3% and the Dow increased around 6.9%. That’s a nice turnaround from last week, which saw each of the indices plunge approximately 6% or more. The big news this week was the election, which finally put to rest a nagging uncertainty for investors. Well, it’s almost put to rest... probably... maybe. Biden appears on his way to victory, but the Trump camp plans to challenge several state results. The market would certainly have loved an official winner on Tuesday, but it’s satiated by the likelihood of a Republican Senate to keep the government divided. However, we’re not exactly certain of that either since there will be a couple run-offs in the New Year. For now though, the market is happy. But it’s anybody’s guess how long that will last amid a new wave of coronavirus cases without a new stimulus package. On Friday, the Dow slipped 0.24% (or about 66 points) to 28,323.40, while the S&P was off 0.03% to 3509.44. Not only did these slight losses end four-day winning streaks for these indices, but it also snapped four straight days with gains north of 1%. In fact, several times this week the advances were closer to 2%. The NASDAQ, though, managed to push its winning run to five days just barely. It was up 0.04% (or around 4 points) to 11,895.23. This index surged 3.85% on Wednesday and 2.59% yesterday as tech really took off after the election on hopes for a split Congress. The pullback may have been more severe but for a strong Government Employment Situation report. The economy added 638,000 jobs last month, which was better than expectations for around 550K. Furthermore, the unemployment rate improved a full percentage point to 6.9% from 7.9% in the previous month. Today's Portfolio Highlights: Insider Trader: Restaurants were all the rage when the pandemic began, but their results started normalizing as restaurants slowly reopened. As a result, organic health food grocer Sprouts Farmers Market (SFM) saw shares drop 18.7% over the past three months. However, a new wave of coronavirus cases may have people cooking at home once again. Perhaps that’s why two insiders recently bought shares of their own company earlier this week. Tracey added two new positions on Friday, and one of them was SFM.   The other buy was Inovalon (INOV), which provides cloud-based data analytics and data-driven intervention platforms for healthcare sector. Shares are down 28.7% after the company lowered its full-year guidance due to expectations for covid-related weakness in the fourth quarter. On October 30, the Chief Administrative Officer, the CEO and a director all bought shares. The editor considers these moves to be both “greedy” insider buys AND votes of confidence that things aren’t as bad as they seem. SFM and INOV were each added with 10% allocations. Read the complete commentary for lots more on these companies. Surprise Trader: Who could’ve known that the mattress and pillow business would be so lucrative? Well, actually, Dave did! He bought Sleep Number (SNBR) in early October and the company just reported a “monster” quarter. The stock is now up more than 28% in the service. The editor grabbed more exposure to the space on Friday by adding Purple Innovation (PRPL), a Zacks Rank #2 (Buy) that crushed the Zacks Consensus Estimate by 145% last time. Now it has a positive Earnings ESP of 5.82% for the quarter coming after the bell on Tuesday, November 10. The portfolio added PRPL today with a 12.5% allocation, while also getting out of the sluggish Cardtronics (CATM) position. Read the full write-up for more. Marijuana Innovators: There’s a lot of good things happening in this portfolio right now after the “green wave” in Tuesday’s elections. You’ve probably heard about the “clean sweep” in state referendums on legalization. Five states took the question right to the voters this week... and all five passed! As a result, Aurora Cannabis (ACB) has more than doubled since Tuesday! It was the best performer yesterday with a surge of 41.5%, and stayed at the top of the mountain today with a further surge of 53.3%. Artelo Biosciences (ARTL) was also a winner on Friday with a rise of 14.9%. But that’s not all. Dave decided to buy GrowGeneration (GRWG), an upstart that owns and operates specialty retail hydroponic and organic gardening stores. Read the editor’s complete commentary for a lot more on GRWG and the brightening prospects for marijuana stocks. Value Investor: You wouldn’t think that the $22 billion agribusiness company Nutrien (NTR) and the luxury homebuilder Toll Brothers (TOL) would have much in common, but they are similar in two ways. They both have solid value characteristics AND they were both added to this portfolio today. NTR launched its digital business at the perfect time... right before the pandemic hit. The company is now “blowing away estimates” with earnings expected to rise 25% this year, though shares remain down more than 17% year-to-date. Meanwhile, TOL is a Zacks Rank #1 (Strong Buy) and part of a strong industry. Shares are down 7% in the past month, but still up 15% this year. Read the complete commentary for a lot more about these moves, including specifics on their value credentials.  Options Trader: "It was another great jobs report and shows just how strong the economy has been bouncing back. "And after Q3's unprecedented GDP growth, and forecasts for a strong Q4, not to mention expectations for 2021 to have the strongest full-year GDP in 38 years, you can see why stocks have been rallying, and why it looks like they will continue to do so. "Let's also not forget about earnings season. It's been doing great. And that should come as no surprise given how strong Q3 GDP was. We have another 1,352 companies reporting earnings next week.   "And lastly, there's still hope for another coronavirus stimulus package by year's end. "We've got an amazing rally underway. And we could see that extended next week." -- Kevin Matras Have a Great Weekend! Jim Giaquinto Recommendations from Zacks' Private Portfolios: Believe it or not, this article is not available on the Zacks.com website. The commentary is a partial overview of the daily activity from Zacks' private recommendation services. If you would like to follow our Buy and Sell signals in real time, we've made a special arrangement for readers of this website. Starting today you can see all the recommendations from all of Zacks' portfolios absolutely free for 7 days. Our services cover everything from value stocks and momentum trades to insider buying and positive earnings surprises (which we've predicted with an astonishing 80%+ accuracy). Click here to "test drive" Zacks Ultimate for FREE >>  Zacks Investment Research.....»»

Category: topSource: zacksSep 21st, 2021

NASDAQ Drops Another 2.7% as Bond Yields Rise Again

NASDAQ Drops Another 2.7% as Bond Yields Rise Again SPECIAL ALERT: Remember, we need your input to make next week’s new Zacks Ultimate Strategy Session episode the best it can be. There are two ways you can participate: 1) Zacks Mailbag: In this regular segment, Kevin Matras answers your questions ranging from current market conditions, general investing wisdom, usage of the Zacks Rank or any resources of Zacks.com and more. Pretty much anything goes.   2) Portfolio Makeover: Sheraz Mian and Daniel Laboe review a customer portfolio to give feedback for improvement. No need to send us personal information such as dollar value of holdings. Simply email us with all of the tickers you own. Just make sure to email your submissions for either one, or both, by Thursday morning, March 4. Email now to mailbag@zacks.com. March started out so positively with a solid rally across the board, but stocks have since pulled back in two consecutive sessions as bond yields move higher. The NASDAQ has now given back all of its 3% surge from two days ago… and then some. The 10-year Treasury yield rose on Wednesday after steadying in the previous two sessions and came awfully close to 1.5% at its peak. Investors are still stinging a bit from the surge past 1.6% last Thursday. If yields are going up, then you can bet that tech is going down. Case in point, the NASDAQ plunged 2.7% (or about 361 points) to 12,997.75. Along with yesterday’s nearly 1.7% slip, the index has now squandered the 3% rally on Monday and closed beneath 13,000 for the first time since January 15. The FAANGs really took their lumps with Netflix (NFLX) plunging 4.95%, while Apple (AAPL), Amazon (AMZN) and Alphabet (GOOG) all dropped more than 2%. Facebook (FB) slipped 1.39%. Meanwhile, Microsoft (MSFT) was off 2.7%. The S&P dropped 1.31% to 3819.72, while the Dow managed better than its counterparts since recovery names are performing pretty well at the moment. The index still slipped 0.39% (or about 121 points) to 31,270.09 despite being in the green for most of the session. These indices are still up for the week thanks to the Monday rally, but not by much. The ADP report showed that private payrolls added 117,000 jobs in February, which was well below expectations north of 200K. The result is all the more disappointing since last month’s print of 174K was three times better than forecasts. On the brighter side, its further proof that the $1.9 trillion stimulus bill in the Senate is still needed, though its kind of a moot point now as the relief is widely expected to pass sometime this month. This isn’t the last we’ll be hearing about jobs this week. Tomorrow comes jobless claims, per usual, and then Friday brings the government employment situation report. Today's Portfolio Highlights: Home Run Investor: The portfolio had a busy Wednesday as it swapped out two positions, which involved selling SailPoint Technologies (SAIL) for a nice 88% return after slipping to a Zacks Rank #4 (Sell). Brian also sold Merit Medical Systems (MMSI) after going nowhere in the service in three months. The new buys are Radius Health (RDUS) and Primoris Services (PRIM). RDUS is a Zacks Rank #2 (Buy) that will maintain the service's healthcare exposure after dropping MMSI. The editor was most impressed with the huge move in estimates for next year to 88 cents from 45 cents, which would mark a return to profitability. PRIM is a Zacks Rank #1 (Strong Buy) construction name that beat in three of the last four quarters. Earnings estimates are rising here too and Brian considers it to be “a bargain”. Read the full write-up for more specifics on today’s action. Insider Trader: Rates for rental cars are still low at the moment, but that will change once travel picks up later this year. Therefore, Tracey added Avis Budget Group (CAR) on Wednesday, a recovery play that’s up 60% in the past month. However, that epic advance did not keep the CFO from buying 6200 shares last week. In fact, this was his second buy of the month. When insiders buy rising stocks, Tracey finds it an especially bullish signal. The editor sold the weak MannKind (MNKD) position today and used its proceeds to buy CAR. The allocation comes to about 7%. Read the full write-up for more. Surprise Trader: The tail end of earnings season is when we get a lot of retailers going to the plate, which is where Dave went for today’s addition. He picked up Zumiez (ZUMZ), a member of the highly-ranked (Top 26%) retail – apparel & shoes industry. The company has a positive Earnings ESP for the quarter being reported after the bell on Thursday, March 11. Last time it beat by over 52%. The editor added ZUMZ on Wednesday, while also selling Travere (TVTX) for a slight loss. Read the full write-up for more. Healthcare Innovators: The market correction is raging right now and could get even more intense moving forward, so Kevin decided to sell a few positions on Wednesday. The big winner was Guardant Health (GH), which was sold for an approximately 80% profit in more than a year. The editor still thinks there’s upside to this diagnostics company, but it has slipped to a Zacks Rank #5 (Strong Sell) due to its guidance. He also cut his losses by selling Vaxart (VXRT) and Quidel (QDEL) today.   Counterstrike: Amid the market’s “wacky” movement of late, Jeremy has been patient when it comes to new moves. But on Wednesday, he felt comfortable enough to buy twice and sell once. The editor picked up Anaplan (PLAN) and The Trade Desk (TTD) with allocations of 5% and 4%, respectively. PLAN is a Zacks Rank #2 (Buy) cloud platform for business applications, which is down sharply despite a strong quarterly report. TTD provides a technology platform for advertising, and it’s getting beaten up during all this tech weakness. The editor thinks both of these names are poised to bounce back moving forward. He also sold BJ’s Wholesale Club (BJ) today for a small loss. See the full write-up for more specifics on all of these moves. TAZR Trader: Vaccine makers have been getting shellacked during all the praise for Johnson & Johnson’s recent single-dose treatment, but Kevin sees a buying opportunity. For example, Novavax (NVAX) has plunged 20% after its report, but a few firms have been raising their price targets on this biotech. The editor thinks this pessimism for vaccine makers is overdone and was willing to add NVAX on Wednesday with a small, 5% allocation to start. Read his full write-up for more. Have a Great Evening, Jim Giaquinto Recommendations from Zacks' Private Portfolios: Believe it or not, this article is not available on the Zacks.com website. The commentary is a partial overview of the daily activity from Zacks' private recommendation services. If you would like to follow our Buy and Sell signals in real time, we've made a special arrangement for readers of this website. Starting today you can see all the recommendations from all of Zacks' portfolios absolutely free for 7 days. Our services cover everything from value stocks and momentum trades to insider buying and positive earnings surprises (which we've predicted with an astonishing 80%+ accuracy). Click here to "test drive" Zacks Ultimate for FREE >>  Zacks Investment Research.....»»

Category: topSource: zacksSep 21st, 2021

Player Personnel: Colorado"s top tech and startup hires in April

While Covid-19 has altered hiring plans for many, the state’s top technology companies and startups continue to bring on personnel during the pandemic. We track the major player personnel moves in our daily newsletter, the Beat. Below, we’.....»»

Category: topSource: bizjournalsMay 4th, 2021

Making moves: The personnel moves in the DFW tech and startup scene in January

Check out the companies making hires in the local tech and startup scene in January......»»

Category: topSource: bizjournalsJan 29th, 2021

Why this Chicago charter bus company acquired a tech startup

A Chicago-based charter bus company that’s been around for more than 15 years has, like many other long-standing and established corporations, made moves to remain tech-forward as consumers increasingly want to use the internet and their phones to ge.....»»

Category: topSource: bizjournalsJul 26th, 2018

2 execs to know: EverlyWell lands exec from Pinterest; Doublehorn promotes COO

Catch up with some of the latest personnel moves in Austin business, including a former exec with Pinterest in Trulia who's now helping a startup sell lab tests that people can perform at home......»»

Category: topSource: bizjournalsFeb 8th, 2019

"Damn You To Hell, You Will Not Destroy America" - Here Is The "Spartacus COVID Letter" That"s Gone Viral

"Damn You To Hell, You Will Not Destroy America" - Here Is The 'Spartacus COVID Letter' That's Gone Viral Via The Automatic Earth blog, This is an anonymously posted document by someone who calls themselves Spartacus. Because it’s anonymous, I can’t contact them to ask for permission to publish. So I hesitated for a while, but it’s simply the best document I’ve seen on Covid, vaccines, etc. Whoever Spartacus is, they have a very elaborate knowledge in “the field”. If you want to know a lot more about the no. 1 issue in the world today, read it. And don’t worry if you don’t understand every single word, neither do I. But I learned a lot. The original PDF doc is here: Covid19 – The Spartacus Letter Hello, My name is Spartacus, and I’ve had enough. We have been forced to watch America and the Free World spin into inexorable decline due to a biowarfare attack. We, along with countless others, have been victimized and gaslit by propaganda and psychological warfare operations being conducted by an unelected, unaccountable Elite against the American people and our allies. Our mental and physical health have suffered immensely over the course of the past year and a half. We have felt the sting of isolation, lockdown, masking, quarantines, and other completely nonsensical acts of healthcare theater that have done absolutely nothing to protect the health or wellbeing of the public from the ongoing COVID-19 pandemic. Now, we are watching the medical establishment inject literal poison into millions of our fellow Americans without so much as a fight. We have been told that we will be fired and denied our livelihoods if we refuse to vaccinate. This was the last straw. We have spent thousands of hours analyzing leaked footage from Wuhan, scientific papers from primary sources, as well as the paper trails left by the medical establishment. What we have discovered would shock anyone to their core. First, we will summarize our findings, and then, we will explain them in detail. References will be placed at the end. Summary: COVID-19 is a blood and blood vessel disease. SARS-CoV-2 infects the lining of human blood vessels, causing them to leak into the lungs. Current treatment protocols (e.g. invasive ventilation) are actively harmful to patients, accelerating oxidative stress and causing severe VILI (ventilator-induced lung injuries). The continued use of ventilators in the absence of any proven medical benefit constitutes mass murder. Existing countermeasures are inadequate to slow the spread of what is an aerosolized and potentially wastewater-borne virus, and constitute a form of medical theater. Various non-vaccine interventions have been suppressed by both the media and the medical establishment in favor of vaccines and expensive patented drugs. The authorities have denied the usefulness of natural immunity against COVID-19, despite the fact that natural immunity confers protection against all of the virus’s proteins, and not just one. Vaccines will do more harm than good. The antigen that these vaccines are based on, SARS-CoV- 2 Spike, is a toxic protein. SARS-CoV-2 may have ADE, or antibody-dependent enhancement; current antibodies may not neutralize future strains, but instead help them infect immune cells. Also, vaccinating during a pandemic with a leaky vaccine removes the evolutionary pressure for a virus to become less lethal. There is a vast and appalling criminal conspiracy that directly links both Anthony Fauci and Moderna to the Wuhan Institute of Virology. COVID-19 vaccine researchers are directly linked to scientists involved in brain-computer interface (“neural lace”) tech, one of whom was indicted for taking grant money from China. Independent researchers have discovered mysterious nanoparticles inside the vaccines that are not supposed to be present. The entire pandemic is being used as an excuse for a vast political and economic transformation of Western society that will enrich the already rich and turn the rest of us into serfs and untouchables. COVID-19 Pathophysiology and Treatments: COVID-19 is not a viral pneumonia. It is a viral vascular endotheliitis and attacks the lining of blood vessels, particularly the small pulmonary alveolar capillaries, leading to endothelial cell activation and sloughing, coagulopathy, sepsis, pulmonary edema, and ARDS-like symptoms. This is a disease of the blood and blood vessels. The circulatory system. Any pneumonia that it causes is secondary to that. In severe cases, this leads to sepsis, blood clots, and multiple organ failure, including hypoxic and inflammatory damage to various vital organs, such as the brain, heart, liver, pancreas, kidneys, and intestines. Some of the most common laboratory findings in COVID-19 are elevated D-dimer, elevated prothrombin time, elevated C-reactive protein, neutrophilia, lymphopenia, hypocalcemia, and hyperferritinemia, essentially matching a profile of coagulopathy and immune system hyperactivation/immune cell exhaustion. COVID-19 can present as almost anything, due to the wide tropism of SARS-CoV-2 for various tissues in the body’s vital organs. While its most common initial presentation is respiratory illness and flu-like symptoms, it can present as brain inflammation, gastrointestinal disease, or even heart attack or pulmonary embolism. COVID-19 is more severe in those with specific comorbidities, such as obesity, diabetes, and hypertension. This is because these conditions involve endothelial dysfunction, which renders the circulatory system more susceptible to infection and injury by this particular virus. The vast majority of COVID-19 cases are mild and do not cause significant disease. In known cases, there is something known as the 80/20 rule, where 80% of cases are mild and 20% are severe or critical. However, this ratio is only correct for known cases, not all infections. The number of actual infections is much, much higher. Consequently, the mortality and morbidity rate is lower. However, COVID-19 spreads very quickly, meaning that there are a significant number of severely-ill and critically-ill patients appearing in a short time frame. In those who have critical COVID-19-induced sepsis, hypoxia, coagulopathy, and ARDS, the most common treatments are intubation, injected corticosteroids, and blood thinners. This is not the correct treatment for COVID-19. In severe hypoxia, cellular metabolic shifts cause ATP to break down into hypoxanthine, which, upon the reintroduction of oxygen, causes xanthine oxidase to produce tons of highly damaging radicals that attack tissue. This is called ischemia-reperfusion injury, and it’s why the majority of people who go on a ventilator are dying. In the mitochondria, succinate buildup due to sepsis does the same exact thing; when oxygen is reintroduced, it makes superoxide radicals. Make no mistake, intubation will kill people who have COVID-19. The end-stage of COVID-19 is severe lipid peroxidation, where fats in the body start to “rust” due to damage by oxidative stress. This drives autoimmunity. Oxidized lipids appear as foreign objects to the immune system, which recognizes and forms antibodies against OSEs, or oxidation-specific epitopes. Also, oxidized lipids feed directly into pattern recognition receptors, triggering even more inflammation and summoning even more cells of the innate immune system that release even more destructive enzymes. This is similar to the pathophysiology of Lupus. COVID-19’s pathology is dominated by extreme oxidative stress and neutrophil respiratory burst, to the point where hemoglobin becomes incapable of carrying oxygen due to heme iron being stripped out of heme by hypochlorous acid. No amount of supplemental oxygen can oxygenate blood that chemically refuses to bind O2. The breakdown of the pathology is as follows: SARS-CoV-2 Spike binds to ACE2. Angiotensin Converting Enzyme 2 is an enzyme that is part of the renin-angiotensin-aldosterone system, or RAAS. The RAAS is a hormone control system that moderates fluid volume in the body and in the bloodstream (i.e. osmolarity) by controlling salt retention and excretion. This protein, ACE2, is ubiquitous in every part of the body that interfaces with the circulatory system, particularly in vascular endothelial cells and pericytes, brain astrocytes, renal tubules and podocytes, pancreatic islet cells, bile duct and intestinal epithelial cells, and the seminiferous ducts of the testis, all of which SARS-CoV-2 can infect, not just the lungs. SARS-CoV-2 infects a cell as follows: SARS-CoV-2 Spike undergoes a conformational change where the S1 trimers flip up and extend, locking onto ACE2 bound to the surface of a cell. TMPRSS2, or transmembrane protease serine 2, comes along and cuts off the heads of the Spike, exposing the S2 stalk-shaped subunit inside. The remainder of the Spike undergoes a conformational change that causes it to unfold like an extension ladder, embedding itself in the cell membrane. Then, it folds back upon itself, pulling the viral membrane and the cell membrane together. The two membranes fuse, with the virus’s proteins migrating out onto the surface of the cell. The SARS-CoV-2 nucleocapsid enters the cell, disgorging its genetic material and beginning the viral replication process, hijacking the cell’s own structures to produce more virus. SARS-CoV-2 Spike proteins embedded in a cell can actually cause human cells to fuse together, forming syncytia/MGCs (multinuclear giant cells). They also have other pathogenic, harmful effects. SARS-CoV- 2’s viroporins, such as its Envelope protein, act as calcium ion channels, introducing calcium into infected cells. The virus suppresses the natural interferon response, resulting in delayed inflammation. SARS-CoV-2 N protein can also directly activate the NLRP3 inflammasome. Also, it suppresses the Nrf2 antioxidant pathway. The suppression of ACE2 by binding with Spike causes a buildup of bradykinin that would otherwise be broken down by ACE2. This constant calcium influx into the cells results in (or is accompanied by) noticeable hypocalcemia, or low blood calcium, especially in people with Vitamin D deficiencies and pre-existing endothelial dysfunction. Bradykinin upregulates cAMP, cGMP, COX, and Phospholipase C activity. This results in prostaglandin release and vastly increased intracellular calcium signaling, which promotes highly aggressive ROS release and ATP depletion. NADPH oxidase releases superoxide into the extracellular space. Superoxide radicals react with nitric oxide to form peroxynitrite. Peroxynitrite reacts with the tetrahydrobiopterin cofactor needed by endothelial nitric oxide synthase, destroying it and “uncoupling” the enzymes, causing nitric oxide synthase to synthesize more superoxide instead. This proceeds in a positive feedback loop until nitric oxide bioavailability in the circulatory system is depleted. Dissolved nitric oxide gas produced constantly by eNOS serves many important functions, but it is also antiviral against SARS-like coronaviruses, preventing the palmitoylation of the viral Spike protein and making it harder for it to bind to host receptors. The loss of NO allows the virus to begin replicating with impunity in the body. Those with endothelial dysfunction (i.e. hypertension, diabetes, obesity, old age, African-American race) have redox equilibrium issues to begin with, giving the virus an advantage. Due to the extreme cytokine release triggered by these processes, the body summons a great deal of neutrophils and monocyte-derived alveolar macrophages to the lungs. Cells of the innate immune system are the first-line defenders against pathogens. They work by engulfing invaders and trying to attack them with enzymes that produce powerful oxidants, like SOD and MPO. Superoxide dismutase takes superoxide and makes hydrogen peroxide, and myeloperoxidase takes hydrogen peroxide and chlorine ions and makes hypochlorous acid, which is many, many times more reactive than sodium hypochlorite bleach. Neutrophils have a nasty trick. They can also eject these enzymes into the extracellular space, where they will continuously spit out peroxide and bleach into the bloodstream. This is called neutrophil extracellular trap formation, or, when it becomes pathogenic and counterproductive, NETosis. In severe and critical COVID-19, there is actually rather severe NETosis. Hypochlorous acid building up in the bloodstream begins to bleach the iron out of heme and compete for O2 binding sites. Red blood cells lose the ability to transport oxygen, causing the sufferer to turn blue in the face. Unliganded iron, hydrogen peroxide, and superoxide in the bloodstream undergo the Haber- Weiss and Fenton reactions, producing extremely reactive hydroxyl radicals that violently strip electrons from surrounding fats and DNA, oxidizing them severely. This condition is not unknown to medical science. The actual name for all of this is acute sepsis. We know this is happening in COVID-19 because people who have died of the disease have noticeable ferroptosis signatures in their tissues, as well as various other oxidative stress markers such as nitrotyrosine, 4-HNE, and malondialdehyde. When you intubate someone with this condition, you are setting off a free radical bomb by supplying the cells with O2. It’s a catch-22, because we need oxygen to make Adenosine Triphosphate (that is, to live), but O2 is also the precursor of all these damaging radicals that lead to lipid peroxidation. The correct treatment for severe COVID-19 related sepsis is non-invasive ventilation, steroids, and antioxidant infusions. Most of the drugs repurposed for COVID-19 that show any benefit whatsoever in rescuing critically-ill COVID-19 patients are antioxidants. N-acetylcysteine, melatonin, fluvoxamine, budesonide, famotidine, cimetidine, and ranitidine are all antioxidants. Indomethacin prevents iron- driven oxidation of arachidonic acid to isoprostanes. There are powerful antioxidants such as apocynin that have not even been tested on COVID-19 patients yet which could defang neutrophils, prevent lipid peroxidation, restore endothelial health, and restore oxygenation to the tissues. Scientists who know anything about pulmonary neutrophilia, ARDS, and redox biology have known or surmised much of this since March 2020. In April 2020, Swiss scientists confirmed that COVID-19 was a vascular endotheliitis. By late 2020, experts had already concluded that COVID-19 causes a form of viral sepsis. They also know that sepsis can be effectively treated with antioxidants. None of this information is particularly new, and yet, for the most part, it has not been acted upon. Doctors continue to use damaging intubation techniques with high PEEP settings despite high lung compliance and poor oxygenation, killing an untold number of critically ill patients with medical malpractice. Because of the way they are constructed, Randomized Control Trials will never show any benefit for any antiviral against COVID-19. Not Remdesivir, not Kaletra, not HCQ, and not Ivermectin. The reason for this is simple; for the patients that they have recruited for these studies, such as Oxford’s ludicrous RECOVERY study, the intervention is too late to have any positive effect. The clinical course of COVID-19 is such that by the time most people seek medical attention for hypoxia, their viral load has already tapered off to almost nothing. If someone is about 10 days post-exposure and has already been symptomatic for five days, there is hardly any virus left in their bodies, only cellular damage and derangement that has initiated a hyperinflammatory response. It is from this group that the clinical trials for antivirals have recruited, pretty much exclusively. In these trials, they give antivirals to severely ill patients who have no virus in their bodies, only a delayed hyperinflammatory response, and then absurdly claim that antivirals have no utility in treating or preventing COVID-19. These clinical trials do not recruit people who are pre-symptomatic. They do not test pre-exposure or post-exposure prophylaxis. This is like using a defibrillator to shock only flatline, and then absurdly claiming that defibrillators have no medical utility whatsoever when the patients refuse to rise from the dead. The intervention is too late. These trials for antivirals show systematic, egregious selection bias. They are providing a treatment that is futile to the specific cohort they are enrolling. India went against the instructions of the WHO and mandated the prophylactic usage of Ivermectin. They have almost completely eradicated COVID-19. The Indian Bar Association of Mumbai has brought criminal charges against WHO Chief Scientist Dr. Soumya Swaminathan for recommending against the use of Ivermectin. Ivermectin is not “horse dewormer”. Yes, it is sold in veterinary paste form as a dewormer for animals. It has also been available in pill form for humans for decades, as an antiparasitic drug. The media have disingenuously claimed that because Ivermectin is an antiparasitic drug, it has no utility as an antivirus. This is incorrect. Ivermectin has utility as an antiviral. It blocks importin, preventing nuclear import, effectively inhibiting viral access to cell nuclei. Many drugs currently on the market have multiple modes of action. Ivermectin is one such drug. It is both antiparasitic and antiviral. In Bangladesh, Ivermectin costs $1.80 for an entire 5-day course. Remdesivir, which is toxic to the liver, costs $3,120 for a 5-day course of the drug. Billions of dollars of utterly useless Remdesivir were sold to our governments on the taxpayer’s dime, and it ended up being totally useless for treating hyperinflammatory COVID-19. The media has hardly even covered this at all. The opposition to the use of generic Ivermectin is not based in science. It is purely financially and politically-motivated. An effective non-vaccine intervention would jeopardize the rushed FDA approval of patented vaccines and medicines for which the pharmaceutical industry stands to rake in billions upon billions of dollars in sales on an ongoing basis. The majority of the public are scientifically illiterate and cannot grasp what any of this even means, thanks to a pathetic educational system that has miseducated them. You would be lucky to find 1 in 100 people who have even the faintest clue what any of this actually means. COVID-19 Transmission: COVID-19 is airborne. The WHO carried water for China by claiming that the virus was only droplet- borne. Our own CDC absurdly claimed that it was mostly transmitted by fomite-to-face contact, which, given its rapid spread from Wuhan to the rest of the world, would have been physically impossible. The ridiculous belief in fomite-to-face being a primary mode of transmission led to the use of surface disinfection protocols that wasted time, energy, productivity, and disinfectant. The 6-foot guidelines are absolutely useless. The minimum safe distance to protect oneself from an aerosolized virus is to be 15+ feet away from an infected person, no closer. Realistically, no public transit is safe. Surgical masks do not protect you from aerosols. The virus is too small and the filter media has too large of gaps to filter it out. They may catch respiratory droplets and keep the virus from being expelled by someone who is sick, but they do not filter a cloud of infectious aerosols if someone were to walk into said cloud. The minimum level of protection against this virus is quite literally a P100 respirator, a PAPR/CAPR, or a 40mm NATO CBRN respirator, ideally paired with a full-body tyvek or tychem suit, gloves, and booties, with all the holes and gaps taped. Live SARS-CoV-2 may potentially be detected in sewage outflows, and there may be oral-fecal transmission. During the SARS outbreak in 2003, in the Amoy Gardens incident, hundreds of people were infected by aerosolized fecal matter rising from floor drains in their apartments. COVID-19 Vaccine Dangers: The vaccines for COVID-19 are not sterilizing and do not prevent infection or transmission. They are “leaky” vaccines. This means they remove the evolutionary pressure on the virus to become less lethal. It also means that the vaccinated are perfect carriers. In other words, those who are vaccinated are a threat to the unvaccinated, not the other way around. All of the COVID-19 vaccines currently in use have undergone minimal testing, with highly accelerated clinical trials. Though they appear to limit severe illness, the long-term safety profile of these vaccines remains unknown. Some of these so-called “vaccines” utilize an untested new technology that has never been used in vaccines before. Traditional vaccines use weakened or killed virus to stimulate an immune response. The Moderna and Pfizer-BioNTech vaccines do not. They are purported to consist of an intramuscular shot containing a suspension of lipid nanoparticles filled with messenger RNA. The way they generate an immune response is by fusing with cells in a vaccine recipient’s shoulder, undergoing endocytosis, releasing their mRNA cargo into those cells, and then utilizing the ribosomes in those cells to synthesize modified SARS-CoV-2 Spike proteins in-situ. These modified Spike proteins then migrate to the surface of the cell, where they are anchored in place by a transmembrane domain. The adaptive immune system detects the non-human viral protein being expressed by these cells, and then forms antibodies against that protein. This is purported to confer protection against the virus, by training the adaptive immune system to recognize and produce antibodies against the Spike on the actual virus. The J&J and AstraZeneca vaccines do something similar, but use an adenovirus vector for genetic material delivery instead of a lipid nanoparticle. These vaccines were produced or validated with the aid of fetal cell lines HEK-293 and PER.C6, which people with certain religious convictions may object strongly to. SARS-CoV-2 Spike is a highly pathogenic protein on its own. It is impossible to overstate the danger presented by introducing this protein into the human body. It is claimed by vaccine manufacturers that the vaccine remains in cells in the shoulder, and that SARS- CoV-2 Spike produced and expressed by these cells from the vaccine’s genetic material is harmless and inert, thanks to the insertion of prolines in the Spike sequence to stabilize it in the prefusion conformation, preventing the Spike from becoming active and fusing with other cells. However, a pharmacokinetic study from Japan showed that the lipid nanoparticles and mRNA from the Pfizer vaccine did not stay in the shoulder, and in fact bioaccumulated in many different organs, including the reproductive organs and adrenal glands, meaning that modified Spike is being expressed quite literally all over the place. These lipid nanoparticles may trigger anaphylaxis in an unlucky few, but far more concerning is the unregulated expression of Spike in various somatic cell lines far from the injection site and the unknown consequences of that. Messenger RNA is normally consumed right after it is produced in the body, being translated into a protein by a ribosome. COVID-19 vaccine mRNA is produced outside the body, long before a ribosome translates it. In the meantime, it could accumulate damage if inadequately preserved. When a ribosome attempts to translate a damaged strand of mRNA, it can become stalled. When this happens, the ribosome becomes useless for translating proteins because it now has a piece of mRNA stuck in it, like a lace card in an old punch card reader. The whole thing has to be cleaned up and new ribosomes synthesized to replace it. In cells with low ribosome turnover, like nerve cells, this can lead to reduced protein synthesis, cytopathic effects, and neuropathies. Certain proteins, including SARS-CoV-2 Spike, have proteolytic cleavage sites that are basically like little dotted lines that say “cut here”, which attract a living organism’s own proteases (essentially, molecular scissors) to cut them. There is a possibility that S1 may be proteolytically cleaved from S2, causing active S1 to float away into the bloodstream while leaving the S2 “stalk” embedded in the membrane of the cell that expressed the protein. SARS-CoV-2 Spike has a Superantigenic region (SAg), which may promote extreme inflammation. Anti-Spike antibodies were found in one study to function as autoantibodies and attack the body’s own cells. Those who have been immunized with COVID-19 vaccines have developed blood clots, myocarditis, Guillain-Barre Syndrome, Bell’s Palsy, and multiple sclerosis flares, indicating that the vaccine promotes autoimmune reactions against healthy tissue. SARS-CoV-2 Spike does not only bind to ACE2. It was suspected to have regions that bind to basigin, integrins, neuropilin-1, and bacterial lipopolysaccharides as well. SARS-CoV-2 Spike, on its own, can potentially bind any of these things and act as a ligand for them, triggering unspecified and likely highly inflammatory cellular activity. SARS-CoV-2 Spike contains an unusual PRRA insert that forms a furin cleavage site. Furin is a ubiquitous human protease, making this an ideal property for the Spike to have, giving it a high degree of cell tropism. No wild-type SARS-like coronaviruses related to SARS-CoV-2 possess this feature, making it highly suspicious, and perhaps a sign of human tampering. SARS-CoV-2 Spike has a prion-like domain that enhances its infectiousness. The Spike S1 RBD may bind to heparin-binding proteins and promote amyloid aggregation. In humans, this could lead to Parkinson’s, Lewy Body Dementia, premature Alzheimer’s, or various other neurodegenerative diseases. This is very concerning because SARS-CoV-2 S1 is capable of injuring and penetrating the blood-brain barrier and entering the brain. It is also capable of increasing the permeability of the blood-brain barrier to other molecules. SARS-CoV-2, like other betacoronaviruses, may have Dengue-like ADE, or antibody-dependent enhancement of disease. For those who aren’t aware, some viruses, including betacoronaviruses, have a feature called ADE. There is also something called Original Antigenic Sin, which is the observation that the body prefers to produce antibodies based on previously-encountered strains of a virus over newly- encountered ones. In ADE, antibodies from a previous infection become non-neutralizing due to mutations in the virus’s proteins. These non-neutralizing antibodies then act as trojan horses, allowing live, active virus to be pulled into macrophages through their Fc receptor pathways, allowing the virus to infect immune cells that it would not have been able to infect before. This has been known to happen with Dengue Fever; when someone gets sick with Dengue, recovers, and then contracts a different strain, they can get very, very ill. If someone is vaccinated with mRNA based on the Spike from the initial Wuhan strain of SARS-CoV-2, and then they become infected with a future, mutated strain of the virus, they may become severely ill. In other words, it is possible for vaccines to sensitize someone to disease. There is a precedent for this in recent history. Sanofi’s Dengvaxia vaccine for Dengue failed because it caused immune sensitization in people whose immune systems were Dengue-naive. In mice immunized against SARS-CoV and challenged with the virus, a close relative of SARS-CoV-2, they developed immune sensitization, Th2 immunopathology, and eosinophil infiltration in their lungs. We have been told that SARS-CoV-2 mRNA vaccines cannot be integrated into the human genome, because messenger RNA cannot be turned back into DNA. This is false. There are elements in human cells called LINE-1 retrotransposons, which can indeed integrate mRNA into a human genome by endogenous reverse transcription. Because the mRNA used in the vaccines is stabilized, it hangs around in cells longer, increasing the chances for this to happen. If the gene for SARS-CoV-2 Spike is integrated into a portion of the genome that is not silent and actually expresses a protein, it is possible that people who take this vaccine may continuously express SARS-CoV-2 Spike from their somatic cells for the rest of their lives. By inoculating people with a vaccine that causes their bodies to produce Spike in-situ, they are being inoculated with a pathogenic protein. A toxin that may cause long-term inflammation, heart problems, and a raised risk of cancers. In the long-term, it may also potentially lead to premature neurodegenerative disease. Absolutely nobody should be compelled to take this vaccine under any circumstances, and in actual fact, the vaccination campaign must be stopped immediately. COVID-19 Criminal Conspiracy: The vaccine and the virus were made by the same people. In 2014, there was a moratorium on SARS gain-of-function research that lasted until 2017. This research was not halted. Instead, it was outsourced, with the federal grants being laundered through NGOs. Ralph Baric is a virologist and SARS expert at UNC Chapel Hill in North Carolina. This is who Anthony Fauci was referring to when he insisted, before Congress, that if any gain-of-function research was being conducted, it was being conducted in North Carolina. This was a lie. Anthony Fauci lied before Congress. A felony. Ralph Baric and Shi Zhengli are colleagues and have co-written papers together. Ralph Baric mentored Shi Zhengli in his gain-of-function manipulation techniques, particularly serial passage, which results in a virus that appears as if it originated naturally. In other words, deniable bioweapons. Serial passage in humanized hACE2 mice may have produced something like SARS-CoV-2. The funding for the gain-of-function research being conducted at the Wuhan Institute of Virology came from Peter Daszak. Peter Daszak runs an NGO called EcoHealth Alliance. EcoHealth Alliance received millions of dollars in grant money from the National Institutes of Health/National Institute of Allergy and Infectious Diseases (that is, Anthony Fauci), the Defense Threat Reduction Agency (part of the US Department of Defense), and the United States Agency for International Development. NIH/NIAID contributed a few million dollars, and DTRA and USAID each contributed tens of millions of dollars towards this research. Altogether, it was over a hundred million dollars. EcoHealth Alliance subcontracted these grants to the Wuhan Institute of Virology, a lab in China with a very questionable safety record and poorly trained staff, so that they could conduct gain-of-function research, not in their fancy P4 lab, but in a level-2 lab where technicians wore nothing more sophisticated than perhaps a hairnet, latex gloves, and a surgical mask, instead of the bubble suits used when working with dangerous viruses. Chinese scientists in Wuhan reported being routinely bitten and urinated on by laboratory animals. Why anyone would outsource this dangerous and delicate work to the People’s Republic of China, a country infamous for industrial accidents and massive explosions that have claimed hundreds of lives, is completely beyond me, unless the aim was to start a pandemic on purpose. In November of 2019, three technicians at the Wuhan Institute of Virology developed symptoms consistent with a flu-like illness. Anthony Fauci, Peter Daszak, and Ralph Baric knew at once what had happened, because back channels exist between this laboratory and our scientists and officials. December 12th, 2019, Ralph Baric signed a Material Transfer Agreement (essentially, an NDA) to receive Coronavirus mRNA vaccine-related materials co-owned by Moderna and NIH. It wasn’t until a whole month later, on January 11th, 2020, that China allegedly sent us the sequence to what would become known as SARS-CoV-2. Moderna claims, rather absurdly, that they developed a working vaccine from this sequence in under 48 hours. Stephane Bancel, the current CEO of Moderna, was formerly the CEO of bioMerieux, a French multinational corporation specializing in medical diagnostic tech, founded by one Alain Merieux. Alain Merieux was one of the individuals who was instrumental in the construction of the Wuhan Institute of Virology’s P4 lab. The sequence given as the closest relative to SARS-CoV-2, RaTG13, is not a real virus. It is a forgery. It was made by entering a gene sequence by hand into a database, to create a cover story for the existence of SARS-CoV-2, which is very likely a gain-of-function chimera produced at the Wuhan Institute of Virology and was either leaked by accident or intentionally released. The animal reservoir of SARS-CoV-2 has never been found. This is not a conspiracy “theory”. It is an actual criminal conspiracy, in which people connected to the development of Moderna’s mRNA-1273 are directly connected to the Wuhan Institute of Virology and their gain-of-function research by very few degrees of separation, if any. The paper trail is well- established. The lab-leak theory has been suppressed because pulling that thread leads one to inevitably conclude that there is enough circumstantial evidence to link Moderna, the NIH, the WIV, and both the vaccine and the virus’s creation together. In a sane country, this would have immediately led to the world’s biggest RICO and mass murder case. Anthony Fauci, Peter Daszak, Ralph Baric, Shi Zhengli, and Stephane Bancel, and their accomplices, would have been indicted and prosecuted to the fullest extent of the law. Instead, billions of our tax dollars were awarded to the perpetrators. The FBI raided Allure Medical in Shelby Township north of Detroit for billing insurance for “fraudulent COVID-19 cures”. The treatment they were using? Intravenous Vitamin C. An antioxidant. Which, as described above, is an entirely valid treatment for COVID-19-induced sepsis, and indeed, is now part of the MATH+ protocol advanced by Dr. Paul E. Marik. The FDA banned ranitidine (Zantac) due to supposed NDMA (N-nitrosodimethylamine) contamination. Ranitidine is not only an H2 blocker used as antacid, but also has a powerful antioxidant effect, scavenging hydroxyl radicals. This gives it utility in treating COVID-19. The FDA also attempted to take N-acetylcysteine, a harmless amino acid supplement and antioxidant, off the shelves, compelling Amazon to remove it from their online storefront. This leaves us with a chilling question: did the FDA knowingly suppress antioxidants useful for treating COVID-19 sepsis as part of a criminal conspiracy against the American public? The establishment is cooperating with, and facilitating, the worst criminals in human history, and are actively suppressing non-vaccine treatments and therapies in order to compel us to inject these criminals’ products into our bodies. This is absolutely unacceptable. COVID-19 Vaccine Development and Links to Transhumanism: This section deals with some more speculative aspects of the pandemic and the medical and scientific establishment’s reaction to it, as well as the disturbing links between scientists involved in vaccine research and scientists whose work involved merging nanotechnology with living cells. On June 9th, 2020, Charles Lieber, a Harvard nanotechnology researcher with decades of experience, was indicted by the DOJ for fraud. Charles Lieber received millions of dollars in grant money from the US Department of Defense, specifically the military think tanks DARPA, AFOSR, and ONR, as well as NIH and MITRE. His specialty is the use of silicon nanowires in lieu of patch clamp electrodes to monitor and modulate intracellular activity, something he has been working on at Harvard for the past twenty years. He was claimed to have been working on silicon nanowire batteries in China, but none of his colleagues can recall him ever having worked on battery technology in his life; all of his research deals with bionanotechnology, or the blending of nanotech with living cells. The indictment was over his collaboration with the Wuhan University of Technology. He had double- dipped, against the terms of his DOD grants, and taken money from the PRC’s Thousand Talents plan, a program which the Chinese government uses to bribe Western scientists into sharing proprietary R&D information that can be exploited by the PLA for strategic advantage. Charles Lieber’s own papers describe the use of silicon nanowires for brain-computer interfaces, or “neural lace” technology. His papers describe how neurons can endocytose whole silicon nanowires or parts of them, monitoring and even modulating neuronal activity. Charles Lieber was a colleague of Robert Langer. Together, along with Daniel S. Kohane, they worked on a paper describing artificial tissue scaffolds that could be implanted in a human heart to monitor its activity remotely. Robert Langer, an MIT alumnus and expert in nanotech drug delivery, is one of the co-founders of Moderna. His net worth is now $5.1 billion USD thanks to Moderna’s mRNA-1273 vaccine sales. Both Charles Lieber and Robert Langer’s bibliographies describe, essentially, techniques for human enhancement, i.e. transhumanism. Klaus Schwab, the founder of the World Economic Forum and the architect behind the so-called “Great Reset”, has long spoken of the “blending of biology and machinery” in his books. Since these revelations, it has come to the attention of independent researchers that the COVID-19 vaccines may contain reduced graphene oxide nanoparticles. Japanese researchers have also found unexplained contaminants in COVID-19 vaccines. Graphene oxide is an anxiolytic. It has been shown to reduce the anxiety of laboratory mice when injected into their brains. Indeed, given SARS-CoV-2 Spike’s propensity to compromise the blood-brain barrier and increase its permeability, it is the perfect protein for preparing brain tissue for extravasation of nanoparticles from the bloodstream and into the brain. Graphene is also highly conductive and, in some circumstances, paramagnetic. In 2013, under the Obama administration, DARPA launched the BRAIN Initiative; BRAIN is an acronym for Brain Research Through Advancing Innovative Neurotechnologies®. This program involves the development of brain-computer interface technologies for the military, particularly non-invasive, injectable systems that cause minimal damage to brain tissue when removed. Supposedly, this technology would be used for healing wounded soldiers with traumatic brain injuries, the direct brain control of prosthetic limbs, and even new abilities such as controlling drones with one’s mind. Various methods have been proposed for achieving this, including optogenetics, magnetogenetics, ultrasound, implanted electrodes, and transcranial electromagnetic stimulation. In all instances, the goal is to obtain read or read-write capability over neurons, either by stimulating and probing them, or by rendering them especially sensitive to stimulation and probing. However, the notion of the widespread use of BCI technology, such as Elon Musk’s Neuralink device, raises many concerns over privacy and personal autonomy. Reading from neurons is problematic enough on its own. Wireless brain-computer interfaces may interact with current or future wireless GSM infrastructure, creating neurological data security concerns. A hacker or other malicious actor may compromise such networks to obtain people’s brain data, and then exploit it for nefarious purposes. However, a device capable of writing to human neurons, not just reading from them, presents another, even more serious set of ethical concerns. A BCI that is capable of altering the contents of one’s mind for innocuous purposes, such as projecting a heads-up display onto their brain’s visual center or sending audio into one’s auditory cortex, would also theoretically be capable of altering mood and personality, or perhaps even subjugating someone’s very will, rendering them utterly obedient to authority. This technology would be a tyrant’s wet dream. Imagine soldiers who would shoot their own countrymen without hesitation, or helpless serfs who are satisfied to live in literal dog kennels. BCIs could be used to unscrupulously alter perceptions of basic things such as emotions and values, changing people’s thresholds of satiety, happiness, anger, disgust, and so forth. This is not inconsequential. Someone’s entire regime of behaviors could be altered by a BCI, including such things as suppressing their appetite or desire for virtually anything on Maslow’s Hierarchy of Needs. Anything is possible when you have direct access to someone’s brain and its contents. Someone who is obese could be made to feel disgust at the sight of food. Someone who is involuntarily celibate could have their libido disabled so they don’t even desire sex to begin with. Someone who is racist could be forced to feel delight over cohabiting with people of other races. Someone who is violent could be forced to be meek and submissive. These things might sound good to you if you are a tyrant, but to normal people, the idea of personal autonomy being overridden to such a degree is appalling. For the wealthy, neural laces would be an unequaled boon, giving them the opportunity to enhance their intelligence with neuroprosthetics (i.e. an “exocortex”), and to deliver irresistible commands directly into the minds of their BCI-augmented servants, even physically or sexually abusive commands that they would normally refuse. If the vaccine is a method to surreptitiously introduce an injectable BCI into millions of people without their knowledge or consent, then what we are witnessing is the rise of a tyrannical regime unlike anything ever seen before on the face of this planet, one that fully intends to strip every man, woman, and child of our free will. Our flaws are what make us human. A utopia arrived at by removing people’s free will is not a utopia at all. It is a monomaniacal nightmare. Furthermore, the people who rule over us are Dark Triad types who cannot be trusted with such power. Imagine being beaten and sexually assaulted by a wealthy and powerful psychopath and being forced to smile and laugh over it because your neural lace gives you no choice but to obey your master. The Elites are forging ahead with this technology without giving people any room to question the social or ethical ramifications, or to establish regulatory frameworks that ensure that our personal agency and autonomy will not be overridden by these devices. They do this because they secretly dream of a future where they can treat you worse than an animal and you cannot even fight back. If this evil plan is allowed to continue, it will spell the end of humanity as we know it. Conclusions: The current pandemic was produced and perpetuated by the establishment, through the use of a virus engineered in a PLA-connected Chinese biowarfare laboratory, with the aid of American taxpayer dollars and French expertise. This research was conducted under the absolutely ridiculous euphemism of “gain-of-function” research, which is supposedly carried out in order to determine which viruses have the highest potential for zoonotic spillover and preemptively vaccinate or guard against them. Gain-of-function/gain-of-threat research, a.k.a. “Dual-Use Research of Concern”, or DURC, is bioweapon research by another, friendlier-sounding name, simply to avoid the taboo of calling it what it actually is. It has always been bioweapon research. The people who are conducting this research fully understand that they are taking wild pathogens that are not infectious in humans and making them more infectious, often taking grants from military think tanks encouraging them to do so. These virologists conducting this type of research are enemies of their fellow man, like pyromaniac firefighters. GOF research has never protected anyone from any pandemic. In fact, it has now started one, meaning its utility for preventing pandemics is actually negative. It should have been banned globally, and the lunatics performing it should have been put in straitjackets long ago. Either through a leak or an intentional release from the Wuhan Institute of Virology, a deadly SARS strain is now endemic across the globe, after the WHO and CDC and public officials first downplayed the risks, and then intentionally incited a panic and lockdowns that jeopardized people’s health and their livelihoods. This was then used by the utterly depraved and psychopathic aristocratic class who rule over us as an excuse to coerce people into accepting an injected poison which may be a depopulation agent, a mind control/pacification agent in the form of injectable “smart dust”, or both in one. They believe they can get away with this by weaponizing the social stigma of vaccine refusal. They are incorrect. Their motives are clear and obvious to anyone who has been paying attention. These megalomaniacs have raided the pension funds of the free world. Wall Street is insolvent and has had an ongoing liquidity crisis since the end of 2019. The aim now is to exert total, full-spectrum physical, mental, and financial control over humanity before we realize just how badly we’ve been extorted by these maniacs. The pandemic and its response served multiple purposes for the Elite: Concealing a depression brought on by the usurious plunder of our economies conducted by rentier-capitalists and absentee owners who produce absolutely nothing of any value to society whatsoever. Instead of us having a very predictable Occupy Wall Street Part II, the Elites and their stooges got to stand up on television and paint themselves as wise and all-powerful saviors instead of the marauding cabal of despicable land pirates that they are. Destroying small businesses and eroding the middle class. Transferring trillions of dollars of wealth from the American public and into the pockets of billionaires and special interests. Engaging in insider trading, buying stock in biotech companies and shorting brick-and-mortar businesses and travel companies, with the aim of collapsing face-to-face commerce and tourism and replacing it with e-commerce and servitization. Creating a casus belli for war with China, encouraging us to attack them, wasting American lives and treasure and driving us to the brink of nuclear armageddon. Establishing technological and biosecurity frameworks for population control and technocratic- socialist “smart cities” where everyone’s movements are despotically tracked, all in anticipation of widespread automation, joblessness, and food shortages, by using the false guise of a vaccine to compel cooperation. Any one of these things would constitute a vicious rape of Western society. Taken together, they beggar belief; they are a complete inversion of our most treasured values. What is the purpose of all of this? One can only speculate as to the perpetrators’ motives, however, we have some theories. The Elites are trying to pull up the ladder, erase upward mobility for large segments of the population, cull political opponents and other “undesirables”, and put the remainder of humanity on a tight leash, rationing our access to certain goods and services that they have deemed “high-impact”, such as automobile use, tourism, meat consumption, and so on. Naturally, they will continue to have their own luxuries, as part of a strict caste system akin to feudalism. Why are they doing this? Simple. The Elites are Neo-Malthusians and believe that we are overpopulated and that resource depletion will collapse civilization in a matter of a few short decades. They are not necessarily incorrect in this belief. We are overpopulated, and we are consuming too many resources. However, orchestrating such a gruesome and murderous power grab in response to a looming crisis demonstrates that they have nothing but the utmost contempt for their fellow man. To those who are participating in this disgusting farce without any understanding of what they are doing, we have one word for you. Stop. You are causing irreparable harm to your country and to your fellow citizens. To those who may be reading this warning and have full knowledge and understanding of what they are doing and how it will unjustly harm millions of innocent people, we have a few more words. Damn you to hell. You will not destroy America and the Free World, and you will not have your New World Order. We will make certain of that. *  *  * This PDF document contains 14 pages, followed by another 17 pages of references. For those, please visit the original PDF file at Covid19 – The Spartacus Letter. *  *  * We try to run the Automatic Earth on donations. Since ad revenue has collapsed, you are now not just a reader, but an integral part of the process that builds this site. Thank you for your support. Support the Automatic Earth in virustime. Donate with Paypal, Bitcoin and Patreon. Tyler Durden Mon, 09/27/2021 - 00:00.....»»

Category: dealsSource: nyt2 hr. 27 min. ago

How to tell if you"re a covert narcissist

Our work-advice columnist tells a reader how to tell if they're a narcissist, plus a look inside Launch House's work-hard-play-hard culture, in Insider Weekly. Welcome back to Insider Weekly! I'm Matt Turner, co-EIC of business at Insider."Am I a covert narcissist?"That's the question at the heart of Rebecca Knight's latest work-advice column this week. Rebecca's spent her career answering these kinds of questions, most often focused on the emotional life of work. As boundaries between home and work blur in the WFH era, they're more relevant than ever.Also in this week's newsletter:Noom markets itself as an anti-diet app. Users say they count calories and receive generic advice from expensive subscriptions.Private-equity firms are locked in a power struggle with their investors, and lawyers are raking in cash no matter what.Launch House allows startup founders to live and work in mansions. Now it's facing scrutiny over safety.Let me know what you think of all our stories at mturner@insider.comSubscribe to Insider for access to all our investigations and features. New to the newsletter? Sign up here. Download our app for news on the go - click here for iOS and here for Android.From narcissism to hybrid life, our work-life columnist tackles tough questions 20th Century Fox Correspondent Rebecca Knight takes us behind the scenes of her work-life column What's Working?:What most interests me about work and careers are the people-problems. When launching my column, "What's Working?", I wanted to find a way to talk about these things and help workers through the challenges they face.Work and home have merged into one in this pandemic. There is much more of an acknowledgement and a focus on what's going on in our personal lives outside of work. The reader questions I'm getting most often are about personality clashes in the remote setup and about people reassessing what they want out of their lives and out of their jobs.My most memorable column so far was about remote-work paranoia. A reader worried: "There must be another Slack channel that everyone else is having fun on and leaving me out of." That reader tapped into something that a lot of us are feeling right now - and as a remote employee myself, I sometimes feel it, too.So that's why it's important to remember that we're all doing our best in this pandemic. Have compassion for yourself and for others. And if you need any advice, send me a question at rknight@insider.com.Read Rebecca's latest column here: 'I always thought that I was a socially anxious introvert. Now I worry I'm a narcissist. What do I do?'Noom says it offers personalized weight-loss support. Users say otherwise. Noom An industry leader in weight-loss apps, Noom has millions of dollars worth of venture-capital funding. It claims to use psychological methods and customized plans to help users lose weight - though users say they largely get cookie-cutter content. While the app sells itself on a concept of psychological reset and long-term weight control, a registered dietician said Noom advises an extremely low daily calorie goal - "It's not really an adult serving size." Here's why some clients reported feeling anxious and burnt out. Get the full story on Noom's canned advice and expensive subscription service.Private-equity firms are locked in a power struggle with their investors Samantha Lee/Insider Private-equity firms and their investors are at each other's throats with expensive demands and competing interests. Legal teams from both parties are caught in the middle, waging a secret war that investor attorneys see as "a game of holding the line." Ambiguous contractual changes between legal teams, firms, and investors muddy the water, and changes are rarely uniform across the industry. The back-and-forth often results in seven-figure legal expenses, as private-equity-firm billing rates can cost up to $1,500 per hour. But the battle, according to one attorney who works for investors, is one-sided in favor of private-equity.Read about the expensive legal war between private-equity firms and their investorsA wild party and COVID outbreak have raised safety concerns for Launch House Eray Alan Los Angeles startup Launch House, a coliving program meant for founders, threw a mismanaged house party with hundreds of guests. Police had to shut it down - but that's part of the "work hard, play hard" ethos of Launch House, according to former residents.While at times, Launch House was poorly controlled and potentially unsafe, with COVID-19 outbreaks and parties, residents also said there were many benefits. A strong community, invaluable network, and fireside chats with like-minded entrepreneurs all remain part of the culture. But the safety concerns have put the company under scrutiny.This is how Launch House plans to move forward - with the help of venture capitalists.More of this week's top reads:Better's CEO has a specific hiring philosophy that allowed him to quadruple its workforce during the pandemic.These 9 BlackRock execs are powering Aladdin, a powerful behind-the-scenes tech software the asset manager has staked its future on.Shopify beat Amazon in one important metric, as competition intensifies between the e-commerce giants.Insider correspondent Kate Taylor exposed Brandy Melville's allegations of discrimination and sexual exploitation. Here's how she got the story. Alphabet life-sciences unit Verily is planning to untangle itself from Google ahead of a potential IPO.This Stitch Fix employee quit during a fiery all-hands meeting. She says stylists are being manipulated and silenced.Investors of cannabis startup Civilized are pushing out the founders. Insider has the full memo.Compiled with help from Phil Rosen, Lisa Ryan and Jordan Erb.Read the original article on Business Insider.....»»

Category: worldSource: nyt20 hr. 42 min. ago

I finally quit my finance job to become a full-time musician - here"s how I"m making the jump

Dane Drewis tried to become a full-time musician a few years ago but fell back on his finance degree. This time, he's making sure it'll be different. Dane Drewis and his guitar. Dane Drewis Dane Drewis is quitting his finance job to pursue music full-time by treating his music like a business. Drewis treats his music like a business and has mapped out a financial strategy to move forward. He recommends acquiring digital production skills for more control over your music. See more stories on Insider's business page. Sometimes you need a nudge to make a leap of faith. But a pandemic lockdown can do the trick, too. Once music gigs dried up during COVID-19 lockdowns, California musician Dane Drewis decided he would quit his corporate finance job and make the jump from part-time to full-time musician. Drewis, who was most recently the VP of finance at design and technology company 14th Round Inc., has done a lot of jobs in his working career: business, finance, waiting tables, and even running a restaurant that Beyoncé invested in.But that list never included music, until now - and that's because he's decided to treat his music like a business venture, not just a side hobby."I'll be turning 39 soon and I've never made a full commitment with music," Drewis told Insider. "I want to be able to look back and say I went all in with music."Drewis, whose parents are both musicians, fell in love with music in college thanks to late-night jam sessions and endless hours practicing guitar alone in his dorm room. But as he took on a professional career, he didn't have the time or energy to go all in. Despite a comfortable salary at his old job and the flexibility to play music on weekends and during evenings, Drewis felt he had to both answer his passion and stop doing what he didn't enjoy. "Honestly I'm tired of doing spreadsheets all day," Drewis said. "I'm ready to share as much happiness and love as possible through committing myself to music."No more safety netsSeveral years ago, Drewis gave up an attempt at becoming a full-time musician because sleeping in his van and living with fewer comforts took its toll. He couldn't secure enough music work to make ends meet and eventually he had to find a full-time job. "Being that broke is stressful and it makes it really hard to be creative," Drewis explained. This time, Drewis has given himself a runway to launch off of - the security of a roof over his head and a nest egg of savings, as well as a more developed financial strategy as opposed to playing music at casinos, weddings, and small-time gigs for low pay."I've done the whole starving artist thing, but it won't be the same this time," Drewis said. "Less scrambling for cash and more consistent work this time, promotional events. I'm treating this like a real business venture."In his previous attempt, Drewis kept his finance degree front and center as his backup plan. The safety net, he said, is ultimately what prevented him from full dedication. "No backup plan this time around," Drewis said. "Before, I was like, 'I can do finance if I need to.' But this time's different. I know for damn sure I don't want to do finance again. That's what's driving me this time."Leveraging digital skills and a business planTo make the jump to full-time musician, Drewis has revamped his digital skills and has used his education to map out a financial strategy for his music business. He shares music on Instagram and is a verified artist on Spotify.He's invested in learning how to produce his own songs rather than relying on a company to produce his music for him - something essential to maintaining creative freedom, Drewis said. A post shared by Dane Drewis (@danedrewis) "I've put a lot of time into learning the software behind music production, tracking and producing my own songs," Drewis said. "I'm taking control over my recordings for my own work."By producing his own music and working on his own timeline, Drewis aims to create original content on a regular basis. Then, he has plans to build out his music-licensing business to get his songs on television commercials and elsewhere. "Ten years ago, I never treated music like a business," Drewis said. "I just saw myself as a singer. But now I see this as a startup company. I know my revenue and expenses. I have a firm business plan."To younger artists looking to make the leap, Drewis recommends becoming as tech-savvy as possible with music production. "[Digital] skill set is the primary currency today," Drewis said. "You want to be your own artist, you want to be able to translate what's in your mind onto the computer and into people's ears, all while making your music sound exactly how you want it to sound." Drewis recommends becoming proficient at Ableton, a production software, as a way of gaining more autonomy as a musician. These tools allow for greater control and customization, he said. Drewis returned from his first international tour in Germany last week, and he has a slew of shows planned for the coming months. His focus remains on building out his digital presence, filming music videos, and growing his audience."For musicians, a big worry is artistic failure," Drewis said. "But a bigger worry, for me, is wondering if I was good enough to really do this. Now's the time to find out." Read the original article on Business Insider.....»»

Category: topSource: businessinsiderSep 25th, 2021

The 6 best treadmills of 2021

An at-home treadmill allows you to improve your cardio, keep fit, and stay healthy. Here are the best treadmills we've tested this year. Table of Contents: Masthead Sticky Treadmills offer an excellent way to increase or maintain your routine cardio and keep fit. The most important qualities to look for in a treadmill are its power, reliability, and run comfort. Our top pick, the ProForm Pro 2000, features iFit workouts, has a cushioned tread, and easily folds up. Few exercise machines have endured the changing landscape of at-home fitness like the treadmill. Not only do they work well for anyone maintaining cardio fitness but they also help runners prepare for things like 5Ks or half marathons. They can even complement a weekly workout routine, especially for those who don't have time to run outside.Treadmills are also simple to use. You simply run or walk on the belt and a motor moves it under your feet at whatever speed you select. Some offer high-tech features like touchscreen displays and live-streamed classes, while others offer a more basic, just-hop-on-and-run experience.As a frequent gym-goer and the Insider Reviews fitness editor, I've run more miles than I can count on treadmills advanced, basic, or otherwise. For every mile logged on something like NordicTrack's Commercial 2950 or ProForm's Pro 2000, I've logged an equal amount (if not many more) on the standard treadmills found at a local gym - i.e. one without an interactive screen attached to it.I leaned on this experience to comb through and test a number of high-quality treadmills currently available. The following guide features a range of treadmill types at various price points in hopes of helping you find the best option for your fitness needs.You'll also find answers to a selection of treadmill FAQs, as well as some insight into how I tested treadmills featured in this guide. Here are the best treadmills 0f 2021 Best overall: ProForm Pro 2000 TreadmillBest smart treadmill: NordicTrack Commercial 2950Best on a budget: Horizon Fitness T101-04 TreadmillBest upright folding model: LifeSpan TR3000i Folding TreadmillBest compact: Cubii ProBest for quiet workouts: 3G Cardio Elite Runner Treadmill How I test treadmills Alyssa Powell/Business Insider Each treadmill featured in this guide went through a series of extensive tests (i.e. I ran on them a lot) to see how well they compared across these four categories: Performance, features, quality, and value. Here's how the categories specifically factored into which treadmills made the cut:Performance: How a treadmill performs comes down to a few basic aspects, including how comfortable it is to run on (and how shock absorbing it is), if it's able to avoid sounding like you're loudly pounding the ground with each step, what its tread feels like underfoot, and how wide the running area is. Though not all treadmills reliably check each of these boxes, a healthy combination of at least three of those often translates to high quality. Features: Some modern treadmills, like those from NordicTrack or ProForm, feature a built-in interactive screen that streams workouts, tracks output metrics, and improves the treadmill's performance. For models that don't have a screen, I looked at how intuitive it was to increase and decrease the treadmill's speed and whether it offered an incline or decline mode. Even those that aren't decked out with the ability to stream workouts are still feature-heavy enough to warrant a spot in your home gym.Quality: If used often, treadmills can take a consistent beating, mostly due to a runner pounding on it step after step after step. This means the best treadmills should feature a sturdy and durable tread, a high-quality design that won't become compromised even after a full year or more of use, and that features an interface or series of buttons and dials that can avoid popping off or being unusable. Value: The value of a treadmill is less about its sticker price and more so the combination of the three categories above compared to its initial (and sometimes recurring) investment. I factored in everything when selecting treadmills across each featured category and often feel that it's worth it to spend a little more money on a product that's designed to last than to spend less, more often on something inferior.  The best treadmill overall ProForm The ProForm Pro 2000 Treadmill is a race-trainers dream that's versatile enough for the casual runner, too. Pros: Good motor, large running belt of 22 by 60 inches, includes both an incline and a decline setting, offers good interval training features, has access to iFit workoutsCons: Customer service may be disappointing if you have problems, very heavy treadmillRunners looking for a treadmill with good all-around training capabilities and a host of useful features will like the reasonably-priced ProForm Pro 2000 Treadmill. It has a 3.5-horsepower motor, which allows it to stand up to daily use, and it boasts a belt deck that measures 22 by 60 inches, which is perfect for most runners. When you're training for races with hills, you'll appreciate this treadmill's ability to reach a 15% incline and a 3% decline, which better simulates hills than most other treadmills — it's easy to adjust it both up and down, too, even while running. The ProForm Pro 2000 also has a number of tech features, including a 7-inch screen that streams iFit's interactive workouts, a music port for iPods, and a built-in fan that works well to keep you (somewhat) cool as you run. Its tread features what the brand calls ProShox Cushioning, which is designed to lessen the impact on your feet and knees while running. Though a true, long-term test of this would better judge its viability, even a handful of runs on it showed that this made a difference (even if it was minimal). What truly makes this treadmill stand out is its inclusion of the above-mentioned iFit workouts. Not only are these excellent ways to keep motivated, but the platform offers some genuinely unique workouts. One day you could be running through France and the next through Vietnam. The globe-spanning locales add a level of quality to the workouts you'd have a hard time finding elsewhere.Another perk of the iFit workouts is how the trainers leading the runs entirely control the incline, decline, and speed, allowing you to focus strictly on running. This is something that's incredibly welcome as fumbling with a treadmill's controls while in a full stride isn't always the most fun (and can easily mess with your cadence). The ProForm Pro 2000 comes with one free year of iFit, too, so you won't have to worry about shelling out a monthly payment for at least 12 months.Its price is also in the range of what you'd expect to pay for a full-featured treadmill. Most interactive workout machines run in the $2,000 range, and the fact this undercuts that average by a few hundred dollars makes it an appealing choice for anyone looking to add a treadmill to their home gym. The best smart treadmill NordicTrack NordicTrack's Commercial 2950 is a highly versatile treadmill that offers automatic incline control, an HD 22-inch touchscreen, and a deep library of interactive classes from iFit. Pros: Now features automatically adjusting resistance and speed, the iFit library offers a wide range of in-studio classes and runs through real-world locales, offers Bluetooth connectivity and WiFi supportCons: ExpensiveThe Commercial 2950 treadmill from NordicTrack is one of the most full-featured machines I've tested, coming with everything from automatic incline control and Bluetooth connectivity to Google Maps integration and personalized workout stats. My favorite feature, however, is its access to iFit's expansive library of interactive workouts. With iFit, you're able to run essentially anywhere, yet still from the comfort of your home. The service's roster of trainers offers a wide range of run types that aren't just confined to a studio or their home (where they do film some of the classes). Rather, you could be running through real-world locales that offer a breath of fresh air from standard treadmill routines. I found this to be a welcome deviation from the tediousness of normal running. Though iFit does cost $39 per month, a free year of the service comes standard with the purchase of all new treadmills.In addition to those workouts, the rest of the 2950 is a premium. The automatically adjusting resistance feature mentioned above is a game-changer, and, as the name suggests, allows the trainers to fully control the incline, decline, and speed of the treadmill as you run along. All you have to worry about is just running — which does well to keep you focused and motivated instead of worrying about fumbling with controls. One nitpick could be that the iFit interface can be a little clunky and slow to use sometimes, and the service occasionally crashed mid-workout (though did tend to load right back up in the exact same spot I was running). This didn't happen enough to be concerning, nor did it detract from my overall experience. What holds the 2950 back from nabbing the top spot in this guide is its price, which is roughly double the cost of the ProForm Pro 200. It's hard for treadmills that have as much as the 2950 in terms of features and available workouts to cost much less than $2,500, so this is still a worthwhile investment for anyone who  certainly isn't cheap but few treadmills with this much to offer both in terms of features and available workouts will necessarily be "affordable." Still, it's worth the investment for those who want access to a huge library of interactive classes and a premium-built treadmill.  The best budget treadmill Horizon Fitness Compared to other budget fold-up treadmills, the Horizon Fitness T101-04 Treadmill has nice features and good performance.Pros: Very good price point for an entry-level treadmill, will save space with a fold-up design, runs quieter than most budget-priced treadmills, works better for walkers and light runnersCons: Only a 55-inch belt length, not really made for high-end running workouts, longevity is questionableSaving space with a fold-up treadmill is a great idea for a lot of people. However, most fold-up treadmills don't offer a lot of power.With those natural limitations of fold-up treadmills in mind, you'll like the Horizon Fitness T101-04 Treadmill, which works well for walkers and anyone on a budget (and isn't really made for runners looking for high-end workouts). Think of it as like an entry-level treadmill, or something that can be a complement to a wider range of at-home equipment. It has a 55-inch belt length, a maximum 10 mph speed, and a 2.25-horsepower motor. The T101-04 treadmill is easy to fold up for storage, which is great for anyone with minimal space in their home or apartment.You can't beat the value, too. If you want something simple, straightforward, and cost-effective that has the basic features necessary for just running and walking, the T101-04 from Horizon Fitness is the treadmill you need. The best upright folding treadmill LifeSpan The LifeSpan TR3000i uses an extensive shock absorption system to take some pressure off your joints while running.Pros: Good price for a mid-range treadmill, unit folds up to save storage space, extensive shock absorption system, good feature set versus other models in this price rangeCons: Not really designed for high-end workouts, build quality of treadmill is questionableSome people dislike working out on a treadmill because of the pressure it places on their joints. The LifeSpan TR3000i attempts to alleviate some of this pressure by using a shock absorption system in the treadmill's deck.It has a 20 x 56-inch running surface, 15 incline levels, and a 6-inch LCD screen that shows your time, calories, distance covered, steps, heart rate, speed, and incline. The eight shock absorber elements in the deck ensure that it remains both stable and comfortable to run on. As mentioned on other models, long-term testing would be a better indicator of just how well the shock-absorbing works, but it's easy to notice the difference in the TR3000i compared to others. If you at all have foot, knee, or joint issues, you'll want to at least consider this one when shopping.Beyond its shock-absorbing capabilities, the TR3000i has a number of fun features to give you variety in your workouts, too, including a tablet holder, a USB charging port, and compatibility with iPods. It also has built-in speakers, folds up for easy storage, and physical console buttons that are sometimes easier to use when making adjustments than only relying on the touchscreen. The best compact treadmill Cubii The Cubii Pro is an easy-to-use, under desk exercise machine that's more of an elliptical than a treadmill but still allows you to log some quality cardio no matter if you're sitting down for lunch or powering through a backlog of emails. Pros: Small, easy-to-use machine that delivers an effective cardio workout, has up to eight different resistance settings, offers companion app supportCons: Not strictly a treadmill, might not be as intense for hardcore fitness buffsThough the Cubii Pro isn't exactly a treadmill in the traditional sense (and is more of an elliptical style machine than anything else), its unobtrusive nature makes it a convenient addition to anyone's home gym. The machine simply sits on the floor, be it under a desk, next to a coffee table, or literally anywhere around the house, and lets you pedal away for as long as you like. The machine delivers low-impact cardio that may benefit those unable to run on a treadmill due to sore joints, and its quiet operation even allows it to be used while watching TV, talking on the phone, or listening to music. With eight different levels of resistance, it affords as easy or as difficult a workout as you like, too. A companion smartphone application lets you keep track of all your logged workouts and lets you set weekly and monthly goals or share your progress with friends. The app is also compatible with services like Fitbit or Apple HealthKit, so if you prefer the interface of those, all workout data can easily sync to them.At $349, it's certainly not a drop in the bucket but it is far cheaper than even the budget model on this list. For convenient, low-impact cardio exercise, the Cubii Pro is as versatile and easy to use as it gets.  The best treadmill for quiet workouts 3G Cardio The 3G Cardio Elite Runner Treadmill delivers excellent performance and runs quieter than most treadmills.Pros: Strong steel frame that will support a lot of weight, unit runs quieter than most treadmills, large treadmill belt area for tall runners, includes a large motor to compare favorably to gym treadmillsCons: Extremely high price point, very heavy equipment that is difficult to move aroundFew treadmills made for use at home will deliver the kind of quiet performance that the 3G Cardio Elite Runner Treadmill delivers. It's made for tall or heavy runners looking for a tough workout, but you'll pay more than $3,000 for the kind of quality that this 3G Cardio unit delivers.It has an Ortho Flex Shock suspension system to minimize the stress of impact for runners, and the 22 by 62-inch platform is perfect for running.The 3G Cardio comes with many pre-programmed workouts and a fitness level test. You have access to speed and elevation settings, heart rate control, and workout customization.  This treadmill also has a 4.0 horsepower motor and 3-inch rollers for great performance.As you would expect with a treadmill with such a high price point, the 3G Cardio Elite consists of thick steel tubing in the frame. It's also rather expensive, so this is really only for serious runners who want a treadmill that will last a lifetime. What treadmills I'm testing next Technogym MyRun ($2,980): Technogym's lineup of cardio machines offers a quality experience on par with the likes of NordicTrack and ProForm, though instead of having iFit workouts, it has its own streaming platform called Technogym Live. The classes on the MyRun tread allow users to run with a trainer, take to a digital beach, or develop a set of goals to work toward. Its full-color display not only streams the content in high-definition but also supplies helpful analytic data that inform how well the workout is going. Matrix Fitness Treadmill TF30 XR ($2,999): A premium-priced treadmill, Matrix Fitness' Treadmill TF30 XR is the entry-level version of the TF30 lineup, but it still offers a quality run experience. This model comes with a built-in screen, speeds up to 12.5 miles per hour, and an incline up to 15%. It also folds up to nearly 90-degrees, making it easy to store. Since I live in a small Brooklyn apartment, this one is very intriguing. Sole Fitness F80 Treadmill ($1,599): Sole's F80 tread looks like some sort of Swiss Army Knife of treadmills, as it has a number of visible bells and whistles. There's an on-board screen that tracks distance run and calories burned (among other stats), handle grips for heart rate monitoring, and a tablet holder (for when you'd rather stream Netflix than watch your mileage slowly tick up). This is close to the kinds of treadmills you'd find at your local gym, so I'm curious as to how it'd function as an at-home option.  FAQs What types of treadmills are there?Basic: The most basic type of treadmill only works for walkers. They will have simple tracking features, such as speed, distance, and time. Most basic units will have a short bed that works better for a walker's stride than for running.And you'll find limited shock absorption features here, which isn't great for runners. Such treadmills will fold up for easy storage (although some more expensive treadmills also can fold up for storage).Mid-range: These treadmills will work for walkers or runners. For walkers, a mid-range treadmill should have longer support arms, allowing you to balance yourself easier. The belt bed will be a bit longer than the basic treadmill but those with longer running strides may still struggle.You'll see better tech features in this price range, including a heart rate monitor worn on the chest or pre-set training programs.Top-end: The highest quality of treadmills will contain long belt beds with good shock absorption, making them perfect for runners. To gain these features, such treadmills rarely will fold up for storage, meaning they require a lot of free space. They will deliver greater maximum speed levels and greater levels of incline, too.These treadmills consist of the highest-quality materials. You'll receive Wi-Fi connectivity and extensive pre-set exercise programs with these models.What are some key treadmill features?Interactive exercise programs: Treadmills may have pre-programmed workouts that can help you with weight loss, cardiovascular performance, speed workouts, or hills training. These programs will allow you to set the length of exercise time, but they will automatically change the speed of the treadmill and the incline to match the parameters of the pre-programmed workout.The ability to incline, decline, and adjust the speed: To help with training for running on hills or for additional calorie burn, the treadmill needs to offer an incline. Most treadmills can reach at least a 12% incline grade. Some treadmills even give you a simulation of running downhill with a decline grade of around 3%.You should be able to adjust the incline, speed, and program in use through the touchscreen monitor. The screen also gives you information on the time elapsed, calories burned, distance traveled, your heart rate, and more. Are there different size treadmill belts?Yes, there are, and it differs for what runners need versus walkers. Runners need a treadmill belt bed of roughly 55-60 inches long, while walkers can use one closer to 45-50 inches long. Taller people will need an even longer belt bed. Remember that the length of the treadmill isn't the same as the length of the bed.The treadmill length (and width, for that matter) must accommodate the base portion of the unit that doesn't move, as well as the bed's motor housing at the front of the unit.A treadmill belt bed should be at least 22 inches wide for runners which provides plenty of space in case you have a misstep. Walkers can successfully use a narrower bed than runners, such as 18 or 20 inches.Are treadmills safe? Many treadmills contain a safety line that hooks into the unit and clips to your shirt. Should you stumble, the safety line disconnects from the treadmill, causing it to shut down immediately. This is a helpful safety feature and it prevents situations where the person using the treadmill falls and gets launched into a wall. It's also recommended that you unplug your treadmill when not in use for added safety. This assures it won't accidentally turn on if a child or pet is around it. Do treadmills have a weight limit? Based on the size of the motor and the shock absorption capabilities, a treadmill may give you a maximum user weight recommendation. You should be able to find this listed in its online user's manual or listed on its specifications sheet.  Read the original article on Business Insider.....»»

Category: worldSource: nytSep 24th, 2021

Charging Up Your Portfolio with Electric Vehicles

Whether its the government, Wall Street investors or even traditional automakers; everybody is seeing tremendous potential in EVs. Ben Rains will show you how to capitalize on this burgeoning space, which grew over 160% worldwide in the first half of 2021. The U.S. Senate passed a $1 trillion bipartisan infrastructure bill in early August, with billions set to flow into various sectors, from more traditional areas such as roads to modern green energy initiatives. The clean energy efforts are part of a larger push within the U.S and other wealthy nations to speed up the transition away from fossil fuels throughout every corner of the economy.The green energy age isn’t complete without electric vehicles (EVs) dominating streets and highways, and the U.S. still has miles of road to travel in order to get there.Washington’s Focus on EVs The White House and Washington have put a spotlight on electric vehicles as part of a longer-term greener movement. President Biden signed an EV-focused executive order in August that hopes to spur rapid adoption. The non-binding goal aims to have all-electric, hydrogen-fuel cell, and plug-in hybrid vehicles make up 50% of U.S. sales by 2030.In order to reach this voluntary benchmark, automakers called for federal support for EV charging stations, various consumer tax incentives, and other pro-electric initiatives. Elsewhere, the Senate’s $1 trillion bill allots $7.5 billion for states and municipalities to build EV charging stations. The legislative effort also includes over $6 billion in grants for battery production, development, and recycling.The projected funding is less than President Biden called for in March when his administration set a goal of building 500,000 public chargers by 2030. There are currently roughly 48,000 public EV charging stations and over 120,000 charging ports in the U.S., according to U.S. Department of Energy data.These levels don’t come close to supporting rapid EV adoption. Federal, state, and local governments must work with automakers, charger technology companies, and various other stakeholders in order for EVs to start driving American automotive sales anytime soon.Despite all of the hype, the U.S. and the world has barely scratched the EV surface. The nascent nature provides plenty of profitable investment opportunities if you know where to look...Continued . . .------------------------------------------------------------------------------------------------------Zacks’ Top Infrastructure Picks (Grab These for Q4 and Beyond)Our research has identified 5 stocks that are set to surge due to the massive new infrastructure bill. This is the largest bill of its kind in decades, giving investors a chance at tremendous gains.Zacks’s just-updated special report, How to Profit from Trillions in Spending for Infrastructure, is designed to help you profit from the most promising “American Upgrade” stocks. Some infrastructure stocks have recently soared as much as +81%... +150%... even +248%.¹ The stocks in this report could be just as lucrative. Don't delay: this Special Report is only available until Sunday, September 26.See 5 Top Infrastructure Stocks Now >>------------------------------------------------------------------------------------------------------The Current EV Market Gasoline-powered vehicles remain by far the most popular means of transportation. Electric vehicles made up only 2% of U.S. sales last year and expanded to a little over 3% in recent months. Limited market share is part of the reason why Wall Street is excited even if the electric/hybrid space doesn’t get close to 50% market share by 2030.Tesla proved there’s demand for EVs in the U.S. and its success on the road and in the stock market forced every established auto company to go all-in on electric. Plus, plenty of newcomers, some of which are publicly traded, are ramping up production on sleek new EVs of all shapes and sizes. It will be difficult to recreate Tesla’s meteoric run, but a few standout startups are starting to make their case.Most major automakers plan to offer many of their current models as EVs within the next decade, while rolling out EV-only cars, SUVs, and trucks. Established auto titans, perhaps ambitiously, aim to generate upwards of 50% of global sales from EVs by 2030.One historic firm is revamping its entire business around EVs. The company said earlier this year it aims to have 40% of its global volume be all electric by 2030 and it expects to spend more than $30 billion on electrification during this stretch. The firm’s early efforts have already paid off in terms of actual sales and its surging stock price.Auto giants in both luxury and mass markets will start eating away at Tesla’s current dominance. There are plenty of reasons to believe this could happen somewhat quickly. A few select stocks will capture a budding corner of the EV market Tesla has little chance of controlling. The ability to meet the coming demand from commercial customers such as contractors, construction companies, police departments, and other government fleets is set to boost a few well-known companies in particular.Where’s the Money  New light-vehicle sales in the U.S. are set to climb around 13% to reach 16.3 million in 2021. EV sales are projected to blow away the broader industry-wide expansion. For instance, global EV sales already skyrocketed over 160% in the first half of 2021 against a pandemic-hit period.Tesla led the charge, accounting for about 14% of the global market during this stretch, but its share slipped compared to last year. A few global automakers are already in Elon Musk’s rearview mirror despite the huge head start, while smaller, highly affordable brands are dominating EV sales in China and other Asian nations.Along with investing in pure-play electric vehicle companies, Wall Street and the industry are pouring money into the technology side of the business. This is vital since EVs rely heavily on interconnected technology, remote software updates, high-tech touch screens, and much more. One firm in September poached a former Tesla executive from Apple—which has its own EV aspirations—because EVs are closer to supercomputers on wheels than traditional cars.EVs will also provide automakers with more consistent revenue streams, via remote monitoring, constant software updates, and other futuristic maintenance necessities. And it’s hardly just the automakers who stand to benefit. Smaller tech companies are already profiting from advanced radar navigation and more, and many are hot acquisition targets. Batteries and Chargers  EV motors are clearly essential cogs, but high-tech batteries are perhaps the most vital components. Continued progress on the energy storage and range fronts will help determine how quickly the market can grow.Wall Street is also laser-focused on lithium, with the commodity making a case to become a “new oil.” Lithium-ion batteries are already used in most portable consumer electronics such as smartphones, and nearly all electric vehicles run on rechargeable lithium-ion batteries.From startups to Tesla, companies are working on next-generation battery technologies, including solid-state batteries and new cell formats. Like many cutting-edge industries, there are likely game-changing batteries coming down the pike soon that few will have imagined possible.Alongside batteries, an EV-heavy future is only possible if consumers can drive anywhere they normally would or make that same big road trip, without needing to plan their route around chargers. EV chargers are often classified in three categories: Level 1, Level 2, and Level 3 or DC fast chargers. The first two are common for home-based charging, while the fittingly named Level 3 fast chargers require as much as $100,000 or more per station in upfront capital.There are over 100 EV charging companies in North America alone. Firms able to create faster chargers that mimic speeds closer to filling up a tank of gas will be surefire superstars, while companies able to roll out the most chargers, akin to gas stations, could become stable green energy players for decades.5 Stocks to Electrify Your Portfolio Electric vehicles and EV-related technologies are some of the most promising spaces investors can target for long-term gains. Consumers are demanding more electric options and manufacturers are rising to the occasion.And as discussed above, the government is driving hard toward a clean energy future. The infrastructure bill passed by the Senate last month could earmark billions of dollars to make EVs even more accessible – and you might be surprised at which stocks might benefit most.To help you make the most of this opportunity, Zacks has just updated our special report, How to Profit from Trillions in Spending for Infrastructure.The report reveals 5 stocks primed for big price moves, including an EV stock no one is thinking about. The company has a new CEO, a new focus on cutting edge tech and earnings that are projected to skyrocket 300%.I encourage you to check out the 5 stocks right away. The infrastructure bill could be a powerful catalyst, but these companies are strong enough to deliver significant gains on their own.Don’t delay. This Special Report is only available until Sunday, September 26.Click here to claim your copy of How to Profit from Trillions in Spending for Infrastructure >>Good Investing,Ben RainsStock Strategist¹ The results listed above are not (or may not be) representative of the performance of all selections made by Zacks Investment Research's newsletter editors and may represent the partial close of a position.  Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksSep 24th, 2021

Futures Slide Alongside Cryptocurrencies Amid China Crackdown

Futures Slide Alongside Cryptocurrencies Amid China Crackdown US futures and European stocks fell amid ongoing nerves over the Evergrande default, while cryptocurrency-linked stocks tumbled after the Chinese central bank said such transactions are illegal. Sovereign bond yields fluctuated after an earlier selloff fueled by the prospect of tighter monetary policy. At 745am ET, S&P 500 e-minis were down 19.5 points, or 0.43%, Nasdaq 100 e-minis were down 88.75 points, or 0.58% and Dow e-minis were down 112 points, or 0.33%. In the biggest overnight news, Evergrande offshore creditors remain in limbo and still haven't received their coupon payment effectively starting the 30-day grace period, while also in China, the State Planner issued a notice on the crackdown of cryptocurrency mining, will strictly prohibit financing for new crypto mining projects and strengthen energy consumption controls of new crypto mining projects. Subsequently, the PBoC issued a notice to further prevent and dispose of the risks from speculating on cryptocurrencies, to strengthen monitoring of risks from crypto trading and such activities are illegal. The news sent the crypto space tumbling as much as 8% while cryptocurrency-exposed stocks slumped in U.S. premarket trading. Marathon Digital (MARA) drops 6.5%, Bit Digital (BTBT) declines 4.7%, Riot Blockchain (RIOT) -5.9%, Coinbase -2.8%. Big banks including JPMorgan, Citigroup, Morgan Stanley and Bank of America Corp slipped about 0.5%, while oil majors Exxon Mobil and Chevron Corp were down 0.4% and 0.3%, respectively, in premarket trading.Mega-cap FAAMG tech giants fell between 0.5% and 0.6%. Nike shed 4.6% after the sportswear maker cut its fiscal 2022 sales expectations and warned of delays during the holiday shopping season. Several analysts lowered their price targets on the maker of sports apparel and sneakers after the company cut its FY revenue growth guidance to mid-single- digits. Here are some of the biggest U.S. movers today: Helbiz (HLBZ) falls 10% after the micromobility company filed with the SEC for the sale of as many as 11m shares by stockholders. Focus Universal (FCUV), an online marketing company that’s been a favorite of retail traders, surged 26% in premarket trading after the stock was cited on Stocktwits in recent days. Vail Resorts (MTN) falls 2.7% in postmarket trading after its full-year forecasts for Ebitda and net income missed at the midpoint. GlycoMimetics (GLYC) jumps 15% postmarket after announcing that efficacy and safety data from a Phase 1/2 study of uproleselan in patients with acute myeloid leukemia were published in the journal Blood on Sept. 16. VTV Therapeutics (VTVT) surges 30% after company says its HPP737 psoriasis treatment showed favorable safety and tolerability profile in a multiple ascending dose study. Fears about a sooner-than-expected tapering amid signs of stalling U.S. economic growth and concerns over a spillover from China Evergrande’s default had rattled investors in September, putting the benchmark S&P 500 index on course to snap a seven-month winning streak. Elaine Stokes, a portfolio manager at Loomis Sayles & Co., told Bloomberg Television, adding that “what they did is tell us that they feel really good about the economy.” While the bond selloff vindicated Treasury bears who argue yields are too low to reflect fundamentals, others see limits to how high they can go. “We’d expected bond yields to go higher, given the macro situation where growth is still very strong,” Sylvia Sheng, global multi-asset strategist with JPMorgan Asset Management, said on Bloomberg Television. “But we do stress that is a modest view, because we think that upside to yields is still limited from here given that central banks including the Fed are still buying bonds.” Still, Wall Street’s main indexes rallied in the past two session and are set for small weekly gains. European equities dipped at the open but trade off worst levels, with the Euro Stoxx 50 sliding as much as 1.1% before climbing off the lows. France's CAC underperformed at the margin. Retail, financial services are the weakest performers. EQT AB, Europe’s biggest listed private equity firm, fell as much as 8.1% after Sweden’s financial watchdog opened an investigation into suspected market abuse. Here are some of the other biggest European movers today: SMCP shares surge as much as 9.9%, advancing for a 9th session in 10, amid continued hopes the financial troubles of its top shareholder will ultimately lead to a sale TeamViewer climbs much as 4.2% after Bankhaus Metzler initiated coverage with a buy rating, citing the company’s above-market growth AstraZeneca gains as much as 3.6% after its Lynparza drug met the primary endpoint in a prostate cancer trial Darktrace drops as much as 9.2%, paring the stock’s rally over the past few weeks, as a technical pattern triggered a sell signal Adidas and Puma fall as much as 4% and 2.9%, respectively, after U.S. rival Nike’s “large cut” to FY sales guidance, which Jefferies said would “likely hurt” shares of European peers Earlier in the session, Asian stocks rose for a second day, led by rallies in Japan and Taiwan, following U.S. peers higher amid optimism over the Federal Reserve’s bullish economic outlook and fading concerns over widespread contagion from Evergrande. Stocks were muted in China and Hong Kong. India’s S&P BSE Sensex topped the 60,000 level for the first time on Friday on optimism that speedier vaccinations will improve demand for businesses in Asia’s third-largest economy. The MSCI Asia Pacific Index gained as much as 0.7%, with TSMC and Sony the biggest boosts. That trimmed the regional benchmark’s loss for the week to about 1%. Japan’s Nikkei 225 climbed 2.1%, reopening after a holiday, pushing its advance for September to 7.7%, the best among major global gauges. The Asian regional benchmark pared its gain as Hong Kong stocks fell sharply in late afternoon trading amid continued uncertainty, with Evergrande giving no sign of making an interest payment that was due Thursday. Among key upcoming events is the leadership election for Japan’s ruling party next week, which will likely determine the country’s next prime minister. “Investor concerns over the Evergrande issue have retreated a bit for now,” said Hajime Sakai, chief fund manager at Mito Securities Co. in Tokyo. “But investors will have to keep downside risk in the corner of their minds.” Indian stocks rose, pushing the Sensex above 60,000 for the first time ever. Key gauges fell in Singapore, Malaysia and Australia, while the Thai market was closed for a holiday. Treasuries are higher as U.S. trading day begins after rebounding from weekly lows reached during Asia session, adding to Thursday’s losses. The 10-year yield was down 1bp at ~1.42%, just above the 100-DMA breached on Thursday for the first time in three months; it climbed to 1.449% during Asia session, highest since July 6, and remains 5.2bp higher on the week, its fifth straight weekly increase. Several Fed speakers are slated, first since Wednesday’s FOMC commentary set forth a possible taper timeline.  Bunds and gilts recover off cheapest levels, curves bear steepening. USTs bull steepen, richening 1.5bps from the 10y point out. Peripheral spreads are wider. BTP spreads widen 2-3bps to Bunds. In FX, the Bloomberg Dollar Spot Index climbed back from a one-week low as concern about possible contagion from Evergrande added to buying of the greenback based on the Federal Reserve tapering timeline signaled on Wednesday. NZD, AUD and CAD sit at the bottom of the G-10 scoreboard. ZAR and TRY are the weakest in EM FX. The pound fell after its rally on Thursday as investors looked ahead to BOE Governor Andrew Bailey’s sPeech next week about a possible interest-rate hike. Traders are betting that in a contest to raise borrowing costs first, the Bank of England will be the runaway winner over the Federal Reserve. The New Zealand and Aussie dollars led declines among Group-of-10 peers. The euro was trading flat, with a week full of events failing “to generate any clear directional move,” said ING analysts Francesco Pesole and Chris Turner. German IFO sentiment indeces will “provide extra indications about the area’s sentiment as  businesses faced a combination of delta variant concerns and lingering supply disruptions”. The Norwegian krone is the best performing currency among G10 peers this week, with Thursday’s announcement from the Norges Bank offering support In commodities, crude futures hold a narrow range up around best levels for the week. WTI stalls near $73.40, Brent near $77.50. Spot gold extends Asia’s gains, adding $12 on the session to trade near $1,755/oz. Base metals are mixed, LME nickel and aluminum drop ~1%, LME tin outperforms with a 2.8% rally. Bitcoin dips after the PBOC says all crypto-related transactions are illegal. Looking to the day ahead now, we’ll hear from Fed Chair Powell, Vice Chair Clarida and the Fed’s Mester, Bowman, George and Bostic, as well as the ECB’s Lane and Elderson, and the BoE’s Tenreyro. Finally, a summit of the Quad Leaders will be held at the White House, including President Biden, and the Prime Ministers of Australia, India and Japan. Market Snapshot S&P 500 futures down 0.3% to 4,423.50 STOXX Europe 600 down 0.7% to 464.18 German 10Y yield fell 8.5 bps to -0.236% Euro little changed at $1.1737 MXAP up 0.4% to 201.25 MXAPJ down 0.5% to 643.20 Nikkei up 2.1% to 30,248.81 Topix up 2.3% to 2,090.75 Hang Seng Index down 1.3% to 24,192.16 Shanghai Composite down 0.8% to 3,613.07 Sensex up 0.2% to 60,031.83 Australia S&P/ASX 200 down 0.4% to 7,342.60 Kospi little changed at 3,125.24 Brent Futures up 0.4% to $77.57/bbl Gold spot up 0.7% to $1,755.38 U.S. Dollar Index little changed at 93.14 Top Overnight News from Bloomberg China Evergrande Group’s unusual silence about a dollar-bond interest payment that was due Thursday has put a focus on what might happen during a 30-day grace period. The Reserve Bank of Australia’s inflation target is increasingly out of step with international counterparts and fails to account for structural changes in the country’s economy over the past 30 years, Westpac Banking Corp.’s Bill Evans said. With central banks from Washington to London this week signaling more alarm over faster inflation, the ultra-stimulative path of the euro zone and some of its neighbors appears lonelier than ever. China’s central bank continued to pump liquidity into the financial system on Friday as policy makers sought to avoid contagion stemming from China Evergrande Group spreading to domestic markets. A more detailed look at global markets courtesy of Newsquawk Asian equity markets traded mixed with the region failing to fully sustain the impetus from the positive performance across global counterparts after the silence from Evergrande and lack of coupon payments for its offshore bonds, stirred uncertainty for the company. ASX 200 (-0.4%) was negative as underperformance in mining names and real estate overshadowed the advances in tech and resilience in financials from the higher yield environment. Nikkei 225 (+2.1%) was the biggest gainer overnight as it played catch up to the prior day’s recovery on return from the Autumnal Equinox holiday in Japan and with exporters cheering the recent risk-conducive currency flows, while KOSPI (-0.1%) was lacklustre amid the record daily COVID-19 infections and after North Korea deemed that it was premature to declare that the Korean War was over. Hang Seng (-1.2%) and Shanghai Comp. (-0.8%) were indecisive after further liquidity efforts by the PBoC were offset by concerns surrounding Evergrande after the Co. failed to make coupon payments due yesterday for offshore bonds but has a 30-day grace period with the Co. remaining quiet on the issue. Finally, 10yr JGBs were lower on spillover selling from global counterparts including the declines in T-notes as the US 10yr yield breached 1.40% for the first time since early-July with the pressure in bonds also stemming from across the Atlantic following a more hawkish BoE, while the presence of the BoJ in the market today for over JPY 1.3tln of government bonds with 1yr-10yr maturities did very little to spur prices. Top Asian News Rivals for Prime Minister Battle on Social Media: Japan Election Asian Stocks Rise for Second Day, Led by Gains in Japan, Taiwan Hong Kong Stocks Still Wagged by Evergrande Tail Hong Kong’s Hang Seng Tech Index Extends Decline to More Than 2% European equities (Stoxx 600 -0.9%) are trading on the back foot in the final trading session of the week amid further advances in global bond yields and a mixed APAC handover. Overnight, saw gains for the Nikkei 225 of 2.1% with the index aided by favourable currency flows, whilst Chinese markets lagged (Shanghai Comp. -0.8%, Hang Seng -1.6%) with further liquidity efforts by the PBoC offset by concerns surrounding Evergrande after the Co. failed to make coupon payments due yesterday for offshore bonds. As context, despite the losses in Europe today, the Stoxx 600 is still higher by some 1.2% on the week. Stateside, futures are also on a softer footing with the ES down by 0.4% ahead of a busy Fed speaker schedule. Back to Europe, sectors are lower across the board with Retail and Personal & Household Goods lagging peers. The former has been hampered by losses in Adidas (-3.0%) following after hours earnings from Nike (-4.2% pre-market) which saw the Co. cut its revenue guidance amid supply chain woes. AstraZeneca (+2.1%) sits at the top of the FTSE 100 after announcing that the Lynparza PROpel trial met its primary endpoint. Daimler’s (+0.1%) Mercedes-Benz has announced that it will take a 33% stake in a battery cell manufacturing JV with Total and Stellantis. EQT (-6.5%) sits at the foot of the Stoxx 600 after the Swedish FSA announced it will open an investigation into the Co. Top European News EQT Investigated by Sweden’s FSA Over Suspected Market Abuse Gazprom Says Claims of Gas Under-supply to Europe Are ‘Absurd’ German Sept. Ifo Business Confidence 98.8; Est. 99 German Business Index at Five-Month Low in Pre-Election Verdict In FX, the rot seems to have stopped for the Buck in terms of its sharp and marked fall from grace amidst post-FOMC reflection and re-positioning in the financial markets on Thursday. Indeed, the Dollar index has regained some poise to hover above the 93.000 level having recoiled from 93.526 to 92.977 over the course of yesterday’s hectic session that saw the DXY register a marginal new w-t-d high and low at either end of the spectrum. Pre-weekend short covering and consolidation may be giving the Greenback a lift, while the risk backdrop is also less upbeat ahead of a raft of Fed speakers flanking US new home sales data. Elsewhere, the Euro remains relatively sidelined and contained against the Buck with little independent inspiration from the latest German Ifo survey as the business climate deteriorated broadly in line with consensus and current conditions were worse than forecast, but business expectations were better than anticipated. Hence, Eur/Usd is still stuck in a rut and only briefly/fractionally outside 1.1750-00 parameters for the entire week, thus far, as hefty option expiry interest continues to keep the headline pair in check. However, there is significantly less support or gravitational pull at the round number today compared to Thursday as ‘only’ 1.3 bn rolls off vs 4.1 bn, and any upside breach could be capped by 1.1 bn between 1.1765-85. CAD/NZD/AUD - Some payback for the non-US Dollars following their revival, with the Loonie waning from 1.2650+ peaks ahead of Canadian budget balances, though still underpinned by crude as WTI hovers around Usd 73.50/brl and not far from decent option expiries (from 1.2655-50 and 1.2625-30 in 1.4 bn each). Similarly, the Kiwi has faded after climbing to within single digits of 0.7100 in wake of NZ trade data overnight revealing a much wider deficit as exports slowed and imports rose, while the Aussie loses grip of the 0.7300 handle and skirts 1.1 bn option expiries at 0.7275. CHF/GBP/JPY - The Franc is fairly flat and restrained following a dovish SNB policy review that left in lagging somewhat yesterday, with Usd/Chf and Eur/Chf straddling 0.9250 and 1.0850 respectively, in contrast to Sterling that is paring some hawkish BoE momentum, as Cable retreats to retest bids circa 1.3700 and Eur/Gbp bounces from sub-0.8550. Elsewhere, the Yen has not been able to fend off further downside through 110.00 even though Japanese participants have returned to the fray after the Autumn Equinox holiday and reports suggest some COVID-19 restrictions may be lifted in 13 prefectures on a trial basis. SCANDI/EM/PM/CRYPTO - A slight change in the pecking order in Scandi-land as the Nok loses some post-Norges Bank hike impetus and the Sek unwinds a bit of its underperformance, but EM currencies are bearing the brunt of the aforementioned downturn in risk sentiment and firmer Usd, with the Zar hit harder than other as Gold is clings to Usd 1750/oz and Try down to deeper post-CBRT rate cut lows after mixed manufacturing sentiment and cap u readings. Meanwhile, Bitcoin is being shackled by the latest Chinese crackdown on mining and efforts to limit risks from what it describes as unlawful speculative crypto currency trading. In commodities, WTI and Brent are set the conclude the week in the green with gains in excess of 2% for WTI at the time of writing; in-spite of the pressure seen in the complex on Monday and the first-half of Tuesday, where a sub USD 69.50/bbl low was printed. Fresh newsflow has, once again, been limited for the complex and continues to focus on the gas situation. More broadly, no update as of yet on the Evergrande interest payment and by all accounts we appear to have entered the 30-day grace period for this and, assuming catalysts remain slim, updates on this will may well dictate the state-of-play. Schedule wise, the session ahead eyes significant amounts of central bank commentary but from a crude perspective the weekly Baker Hughes rig count will draw attention. On the weather front, Storm Sam has been upgraded to a Hurricane and is expected to rapidly intensify but currently remains someway into the mid-Atlantic. Moving to metals, LME copper is pivoting the unchanged mark after a mixed APAC lead while attention is on Glencore’s CSA copper mine, which it has received an offer for; the site in 2020 produced circa. 46k/T of copper which is typically exported to Asia smelters. Elsewhere, spot gold and silver are firmer but have been very contained and remain well-within overnight ranges thus far. Which sees the yellow metal holding just above the USD 1750/oz mark after a brief foray below the level after the US-close. US Event Calendar 10am: Aug. New Home Sales MoM, est. 1.0%, prior 1.0% 10am: Aug. New Home Sales, est. 715,000, prior 708,000 Central Bank Speakers 8:45am: Fed’s Mester Discusses the Economic Outlook 10am: Powell, Clarida and Bowman Host Fed Listens Event 10:05am: Fed’s George Discusses Economic Outlook 12pm: Fed’s Bostic Discusses Equitable Community Development DB's Jim Reid concludes the overnight wrap WFH today is a bonus as it’s time for the annual ritual at home where the latest, sleekest, shiniest iPhone model arrives in the post and i sheepishly try to justify to my wife when I get home why I need an incremental upgrade. This year to save me from the Spanish Inquisition I’m going to intercept the courier and keep quiet. Problem is that such speed at intercepting the delivery will be logistically challenging as I remain on crutches (5 weeks to go) and can’t grip properly with my left hand due to an ongoing trapped nerve. I’m very glad I’m not a racehorse. Although hopefully I can be put out to pasture in front of the Ryder Cup this weekend. The big news of the last 24 hours has been a galloping global yield rise worthy of the finest thoroughbred. A hawkish Fed meeting, with the dots increasing and the end of QE potentially accelerated, didn’t quite have the ability to move markets but the global dam finally broke yesterday with Norway being the highest profile developed country to raise rates this cycle (expected), but more importantly a Bank of England meeting that saw the market reappraise rate hikes. Looking at the specific moves, yields on 10yr Treasuries were up +13.0bps to 1.430% in their biggest daily increase since 25 February, as both higher real rates (+7.9bps) and inflation breakevens (+4.9bps) drove the advance. US 10yr yields had been trading in a c.10bp range for the last month before breaking out higher, though they have been trending higher since dropping as far as 1.17% back in early-August. US 30yr yields rose +13.2bps, which was the biggest one day move in long dated yields since March 17 2020, which was at the onset of the pandemic and just days after the Fed announced it would be starting the current round of QE. The large selloff in US bonds saw the yield curve steepen and the long-end give back roughly half of the FOMC flattening from the day before. The 5y30y curve steepened 3.4bps for a two day move of -3.3bps. However the 2y10y curve steepened +10.5bps, completely reversing the prior day’s flattening (-4.2bps) and leaving the spread at 116bp, the steepest level since first week of July. 10yr gilt yields saw nearly as strong a move (+10.8bps) with those on shorter-dated 2yr gilts (+10.7bps) hitting their highest level (0.386%) since the pandemic began.That came on the back of the BoE’s latest policy decision, which pointed in a hawkish direction, building on the comment in the August statement that “some modest tightening of monetary policy over the forecast period is likely to be necessary” by saying that “some developments during the intervening period appear to have strengthened that case”. The statement pointed out that the rise in gas prices since August represented an upside risks to their inflation projections from next April, and the MPC’s vote also saw 2 members (up from 1 in August) vote to dial back QE. See DB’s Sanjay Raja’s revised rate hike forecasts here. We now expect a 15bps hike in February. The generalised move saw yields in other European countries rise as well, with those on 10yr bunds (+6.6bps), OATs (+6.5bps) and BTPs (+5.7bps) all seeing big moves higher with 10yr bunds seeing their biggest climb since late-February and back to early-July levels as -0.258%. The yield rise didn’t stop equity indices recovering further from Monday’s rout, with the S&P 500 up +1.21% as the index marked its best performance in over 2 months, and its best 2-day performance since May. Despite the mood at the end of the weekend, the S&P now starts Friday in positive territory for the week. The rally yesterday was led by cyclicals for a second straight day with higher commodity prices driving outsized gains for energy (+3.41%) and materials (+1.39%) stocks, and the aforementioned higher yields causing banks (+3.37%) and diversified financials (+2.35%) to outperform. The reopening trade was the other main beneficiary as airlines rose +2.99% and consumer services, which include hotel and cruiseline companies, gained +1.92%. In Europe, the STOXX 600 (+0.93%) witnessed a similarly strong performance, with index led by banks (+2.16%). As a testament to the breadth of yesterday’s rally, the travel and leisure sector (+0.04%) was the worst performing sector on this side of the Atlantic even while registering a small gain and lagging its US counterparts. Before we get onto some of yesterday’s other events, it’s worth noting that this is actually the last EMR before the German election on Sunday, which has long been signposted as one of the more interesting macro events on the 2021 calendar, the results of which will play a key role in not just domestic, but also EU policy. And with Chancellor Merkel stepping down after four terms in office, this means that the country will soon be under new management irrespective of who forms a government afterwards. It’s been a volatile campaign in many respects, with Chancellor Merkel’s CDU/CSU, the Greens and the centre-left SPD all having been in the lead at various points over the last six months. But for the last month Politico’s Poll of Polls has shown the SPD consistently ahead, with their tracker currently putting them on 25%, ahead of the CDU/CSU on 22% and the Greens on 16%. However the latest poll from Forschungsgruppe Wahlen yesterday suggested a tighter race with the SPD at 25, the CDU/CSU at 23% and the Greens at 16.5%. If the actual results are in line with the recent averages, it would certainly mark a sea change in German politics, as it would be the first time that the SPD have won the popular vote since the 2002 election. Furthermore, it would be the CDU/CSU’s worst ever result, and mark the first time in post-war Germany that the two main parties have failed to win a majority of the vote between them, which mirrors the erosion of the traditional big parties in the rest of continental Europe. For the Greens, 15% would be their best ever score, and exceed the 9% they got back in 2017 that left them in 6th place, but it would also be a disappointment relative to their high hopes back in the spring, when they were briefly polling in the mid-20s after Annalena Baerbock was selected as their Chancellor candidate. In terms of when to expect results, the polls close at 17:00 London time, with initial exit polls released immediately afterwards. However, unlike the UK, where a new majority government can immediately come to power the day after the election, the use of proportional representation in Germany means that it could potentially be weeks or months before a new government is formed. Indeed, after the last election in September 2017, it wasn’t until March 2018 that the new grand coalition between the CDU/CSU and the SPD took office, after attempts to reach a “Jamaica” coalition between the CDU/CSU, the FDP and the Greens was unsuccessful. In the meantime, the existing government will act as a caretaker administration. On the policy implications, it will of course depend on what sort of government is actually formed, but our research colleagues in Frankfurt have produced a comprehensive slidepack (link here) running through what the different parties want across a range of policies, and what the likely coalitions would mean for Germany. They also put out another note yesterday (link here) where they point out that there’s still much to play for, with the SPD’s lead inside the margin of error and with an unusually high share of yet undecided voters. Moving on to Asia and markets are mostly higher with the Nikkei (+2.04%), CSI (+0.53%) and India’s Nifty (+0.52%) up while the Hang Seng (-0.03%), Shanghai Comp (-0.07%) and Kospi (-0.10%) have all made small moves lower. Meanwhile, the Evergrande group missed its dollar bond coupon payment yesterday and so far there has been no communication from the group on this. They have a 30-day grace period to make the payment before any event of default can be declared. This follows instructions from China’s Financial regulators yesterday in which they urged the group to take all measures possible to avoid a near-term default on dollar bonds while focusing on completing unfinished properties and repaying individual investors. Yields on Australia and New Zealand’s 10y sovereign bonds are up +14.5bps and +11.3bps respectively this morning after yesterday’s move from their western counterparts. Yields on 10y USTs are also up a further +1.1bps to 1.443%. Elsewhere, futures on the S&P 500 are up +0.04% while those on the Stoxx 50 are down -0.10%. In terms of overnight data, Japan’s August CPI printed at -0.4% yoy (vs. -0.3% yoy expected) while core was unchanged in line with expectations. We also received Japan’s flash PMIs with the services reading at 47.4 (vs. 42.9 last month) while the manufacturing reading came in at 51.2 (vs. 52.7 last month). In pandemic related news, Jiji reported that Japan is planning to conduct trials of easing Covid restrictions, with 13 prefectures indicating they’d like to participate. This is likely contributing to the outperformance of the Nikkei this morning. Back to yesterday now, and one of the main highlights came from the flash PMIs, which showed a continued deceleration in growth momentum across Europe and the US, and also underwhelmed relative to expectations. Running through the headline numbers, the Euro Area composite PMI fell to 56.1 (vs. 58.5 expected), which is the lowest figure since April, as both the manufacturing (58.7 vs 60.3 expected) and services (56.3 vs. 58.5 expected) came in beneath expectations. Over in the US, the composite PMI fell to 54.5 in its 4th consecutive decline, as the index hit its lowest level in a year, while the UK’s composite PMI at 54.1 (vs. 54.6 expected) was the lowest since February when the country was still in a nationwide lockdown. Risk assets seemed unperturbed by the readings, and commodities actually took another leg higher as they rebounded from their losses at the start of the week. The Bloomberg Commodity Spot index rose +1.12% as Brent crude oil (+1.39%) closed at $77.25/bbl, which marked its highest closing level since late 2018, while WTI (+1.07%) rose to $73.30/bbl, so still a bit beneath its recent peak in July. However that is a decent rebound of roughly $11/bbl since its recent low just over a month ago. Elsewhere, gold (-1.44%) took a knock amidst the sharp move higher in yields, while European natural gas prices subsidised for a third day running, with futures now down -8.5% from their intraday peak on Tuesday, although they’re still up by +71.3% since the start of August. US negotiations regarding the upcoming funding bill and raising the debt ceiling are ongoing, with House Speaker Pelosi saying that the former, also called a continuing resolution, will pass “both houses by September 30,” and fund the government through the first part of the fiscal year, starting October 1. Treasury Secretary Yellen has said the US will likely breach the debt ceiling sometime in the next month if Congress does not increase the level, and because Republicans are unwilling to vote to raise the ceiling, Democrats will have to use the once-a-fiscal-year tool of budget reconciliation to do so. However Democrats, are also using that process for the $3.5 trillion dollar economic plan that makes up the bulk of the Biden agenda, and have not been able to get full party support yet. During a joint press conference with Speaker Pelosi, Senate Majority Leader Schumer said that Democrats have a “framework” to pay for the Biden Economic agenda, which would imply that the broad outline of a deal was reached between the House, Senate and the White House. However, no specifics were mentioned yesterday. With Democrats looking to vote on the bipartisan infrastructure bill early next week, negotiations today and this weekend on the potential reconciliation package will be vital. Looking at yesterday’s other data, the weekly initial jobless claims from the US for the week through September 18 unexpectedly rose to 351k (vs. 320k expected), which is the second week running they’ve come in above expectations. Separately, the Chicago Fed’s national activity index fell to 0.29 in August (vs. 0.50 expected), and the Kansas City Fed’s manufacturing activity index also fell more than expected to 22 in September (vs. 25 expected). To the day ahead now, and data highlights include the Ifo’s business climate indicator from Germany for September, along with Italian consumer confidence for September and US new home sales for August. From central banks, we’ll hear from Fed Chair Powell, Vice Chair Clarida and the Fed’s Mester, Bowman, George and Bostic, as well as the ECB’s Lane and Elderson, and the BoE’s Tenreyro. Finally, a summit of the Quad Leaders will be held at the White House, including President Biden, and the Prime Ministers of Australia, India and Japan. Tyler Durden Fri, 09/24/2021 - 08:12.....»»

Category: blogSource: zerohedgeSep 24th, 2021

Futures Rise On Taper, Evergrande Optimism

Futures Rise On Taper, Evergrande Optimism US index futures jumped overnight even as the Fed confirmed that a November tapering was now guaranteed and would be completed by mid-2022 with one rate hike now on deck, while maintaining the possibility to extend stimulus if necessitated by the economy. Sentiment got an additional boost from a strong showing of Evergrande stock - which closed up 17% - during the Chinese session, which peaked just after Bloomberg reported that China told Evergrande to avoid a near-term dollar bond default and which suggested that the "government wants to avoid an imminent collapse of the developer" however that quickly reversed when the WSJ reported, just one hour later, that China was making preparations for Evergrande's demise, and although that hammered stocks, the report explicitly noted that a worst-case scenario for Evergrande would mean a partial or full nationalization as "local-level government agencies and state-owned enterprises have been instructed to step in only at the last minute should Evergrande fail to manage its affairs in an orderly fashion." In other words, both reports are bullish: either foreign creditors are made whole (no default) as per BBG or the situation deteriorates and Evergrande is nationalized ("SOEs step in") as per WSJ. According to Bloomberg, confidence is building that markets can ride out a pullback in Fed stimulus, unlike 2013 when the taper tantrum triggered large losses in bonds and equities. "Investors are betting that the economic and profit recovery will be strong enough to outweigh a reduction in asset purchases, while ultra-low rates will continue to support riskier assets even as concerns linger about contagion from China’s real-estate woes." That's one view: the other is that the Fed has so broken the market's discounting ability we won't know just how bad tapering will get until it actually begins. “The Fed has got to be pleased that their communication on the longer way to tapering has avoided the dreaded fear of the tantrum,” Jeffrey Rosenberg, senior portfolio manager for systematic fixed income at BlackRock Inc., said on Bloomberg Television. “This is a very good outcome for the Fed in terms of signaling their intent to give the market information well ahead of the tapering decision.” Then there is the question of Evergrande: “With regards to Evergrande, all those people who are waiting for a Lehman moment in China will probably have to wait another turn,” said Ken Peng, an investment strategist at Citi Private Bank Asia Pacific. “So I wouldn’t treat this as completely bad, but there are definitely a lot of risks on the horizon.” In any case, today's action is a continuation of the best day in two months for both the Dow and the S&P which staged a strong recovery from two-month lows hit earlier in the week, and as of 745am ET, S&P 500 E-minis were up 25.25 points, or 0.6%, Dow E-minis were up 202 points, or 0.59%, while Nasdaq 100 E-minis were up 92.0 points, or 0.60%. In the premarket, electric vehicle startup Lucid Group rose 3.1% in U.S. premarket trading. PAVmed (PVM US) jumps 11% after its Lucid Diagnostics unit announced plans to list on the Global Market of the Nasdaq Stock Market.  Here are some of the biggest movers today: U.S.-listed Chinese stocks rise in premarket trading as fears of contagion from China Evergrande Group’s debt crisis ease. Blackberry (BB US) shares rise 8.7% in premarket after co.’s 2Q adjusted revenue beat the average of analysts’ estimates Eargo (EAR US) falls 57% in Thursday premarket after the hearing aid company revealed it was the target of a Justice Department criminal probe and withdrew its forecasts for the year Amplitude Healthcare Acquisition (AMHC US) doubled in U.S. premarket trading after the SPAC’s shareholders approved the previously announced business combination with Jasper Therapeutics Steelcase (SCS US) fell 4.8% Wednesday postmarket after the office products company reported revenue for the second quarter that missed the average analyst estimate Vertex Energy Inc. (VTNR US) gained 2.1% premarket after saying the planned acquisition of a refinery in Mobile, Alabama from Royal DutVTNR US Equitych Shell Plc is on schedule Synlogic (SYBX US) shares declined 9.7% premarket after it launched a stock offering launched without disclosing a size HB Fuller (FUL US) climbed 2.7% in postmarket trading after third quarter sales beat even the highest analyst estimate Europe's Stoxx 600 index rose 0.9%, lifted by carmakers, tech stocks and utilities, which helped it recover losses sparked earlier in the week by concerns about Evergrande and China’s crackdown on its property sector. The gauge held its gain after surveys of purchasing managers showed business activity in the euro area lost momentum and slowed broadly in September after demand peaked over the summer and supply-chain bottlenecks hurt services and manufacturers. Euro Area Composite PMI (September, Flash): 56.1, consensus 58.5, last 59.0. Euro Area Manufacturing PMI (September, Flash): 58.7, consensus 60.3, last 61.4. Euro Area Services PMI (September, Flash): 56.3, consensus 58.5, last 59.0. Germany Composite PMI (September, Flash): 55.3, consensus 59.2, last 60.0. France Composite PMI (September, Flash): 55.1, consensus 55.7, last 55.9. UK Composite PMI (September, Flash): 54.1, consensus 54.6, last 54.8. Commenting on Europe's PMIs, Goldman said that the Euro area composite PMI declined by 2.9pt to 56.1 in September, well below consensus expectations. The softening was broad-based across countries but primarily led by Germany. The peripheral composite flash PMI also weakened significantly in September but remain very high by historical standards (-2.4pt to 57.5). Across sectors, the September composite decline was also broad-based, with manufacturing output softening (-3.3pt to 55.6) to a similar extent as services (-2.7pt to 56.3). Supply-side issues and upward cost and price pressures continued to be widely reported. Expectations of future output growth declined by less than spot output on the back of delta variant worries and supply issues, remaining far above historically average levels. Earlier in the session, Asian stocks rose for the first time in four sessions, as Hong Kong helped lead a rally on hopes that troubled property firm China Evergrande Group will make progress on debt repayment. The MSCI Asia Pacific Index climbed as much as 0.5%, with Tencent and Meituan providing the biggest boosts. The Hang Seng jumped as much as 2.5%, led by real estate stocks as Evergrande surged more than 30%. Hong Kong shares later pared their gains. Asian markets were also cheered by gains in U.S. stocks overnight even as the Federal Reserve said it may begin scaling back stimulus this year. A $17 billion net liquidity injection from the People’s Bank of China also provided a lift, while the Fed and Bank of Japan downplayed Evergrande risks in comments accompanying policy decisions Wednesday. Evergrande’s stock closed 18% higher in Hong Kong, in a delayed reaction to news a unit of the developer had negotiated interest payments on yuan notes. A coupon payment on its 2022 dollar bond is due on Thursday “Investors are perhaps reassessing the tail risk of a disorderly fallout from Evergrande’s credit issues,” said Chetan Seth, a strategist at Nomura. “However, I am not sure if the fundamental issue around its sustainable deleveraging has been addressed. I suspect markets will likely remain quite volatile until we have some definite direction from authorities on the eventual resolution of Evergrande’s debt problems.” Stocks rose in most markets, with Australia, Taiwan, Singapore and India also among the day’s big winners. South Korea’s benchmark was the lone decliner, while Japan was closed for a holiday In rates, Treasuries were off session lows, with the 10Y trading a 1.34%, but remained under pressure in early U.S. session led by intermediate sectors, where 5Y yield touched highest since July 2. Wednesday’s dramatic yield-curve flattening move unleashed by Fed communications continued, compressing 5s30s spread to 93.8bp, lowest since May 2020. UK 10-year yield climbed 3.4bp to session high 0.833% following BOE rate decision (7-2 vote to keep bond-buying target unchanged); bunds outperformed slightly. Peripheral spreads tighten with long-end Italy outperforming. In FX, the Bloomberg Dollar Spot Index reversed an earlier gain and dropped 0.3% as the dollar weakened against all of its Group-of-10 peers apart from the yen amid a more positive sentiment. CAD, NOK and SEK are the strongest performers in G-10, JPY the laggard.  The euro and the pound briefly pared gains after weaker-than-forecast German and British PMIs. The pound rebounded from an eight-month low amid a return of global risk appetite as investors assessed whether the Bank of England will follow the Federal Reserve’s hawkish tone later Thursday. The yield differential between 10-year German and Italian debt narrowed to its tightest since April. Norway’s krone advanced after Norges Bank raised its policy rate in line with expectations and signaled a faster pace of tightening over the coming years. The franc whipsawed as the Swiss National Bank kept its policy rate and deposit rate at record lows, as expected, and reiterated its pledge to wage currency market interventions. The yen fell as a unit of China Evergrande said it had reached an agreement with bond holders over an interest payment, reducing demand for haven assets. Turkey’s lira slumped toa record low against the dollar after the central bank unexpectedly cut interest rates. In commodities, crude futures drifted lower after a rangebound Asia session. WTI was 0.25% lower, trading near $72; Brent dips into the red, so far holding above $76. Spot gold adds $3.5, gentle reversing Asia’s losses to trade near $1,771/oz. Base metals are well bid with LME aluminum leading gains. Bitcoin steadied just below $44,000. Looking at the day ahead, we get the weekly initial jobless claims, the Chicago Fed’s national activity index for August, and the Kansas City fed’s manufacturing activity index for September. From central banks, there’ll be a monetary policy decision from the Bank of England, while the ECB will be publishing their Economic Bulletin and the ECB’s Elderson will also speak. From emerging markets, there’ll also be monetary policy decisions from the Central Bank of Turkey and the South African Reserve Bank. Finally in Germany, there’s an election debate with the lead candidates from the Bundestag parties. Market Snapshot S&P 500 futures up 0.7% to 4,413.75 STOXX Europe 600 up 1.1% to 468.32 MXAP up 0.5% to 200.57 MXAPJ up 0.9% to 645.76 Nikkei down 0.7% to 29,639.40 Topix down 1.0% to 2,043.55 Hang Seng Index up 1.2% to 24,510.98 Shanghai Composite up 0.4% to 3,642.22 Sensex up 1.4% to 59,728.37 Australia S&P/ASX 200 up 1.0% to 7,370.22 Kospi down 0.4% to 3,127.58 German 10Y yield fell 5.6 bps to -0.306% Euro up 0.4% to $1.1728 Brent Futures up 0.3% to $76.39/bbl Gold spot up 0.0% to $1,768.25 U.S. Dollar Index down 0.33% to 93.16 Top Overnight News from Bloomberg Financial regulators in Beijing issued a broad set of instructions to China Evergrande Group, telling the embattled developer to focus on completing unfinished properties and repaying individual investors while avoiding a near-term default on dollar bonds China’s central bank net-injected the most short- term liquidity in eight months into the financial system, with markets roiled by concerns over China Evergrande Group’s debt crisis Europe’s worst energy crisis in decades could drag deep into the cold months as Russia is unlikely to boost shipments until at least November Business activity in the euro area “markedly” lost momentum in September after demand peaked over the summer and supply chain bottlenecks hurt both services and manufacturers. Surveys of purchasing managers by IHS Markit showed growth in both sectors slowing more than expected, bringing overall activity to a five-month low. Input costs, meanwhile, surged to the highest in 21 years, according to the report The U.K. private sector had its weakest month since the height of the winter lockdown and inflation pressures escalated in September, adding to evidence that the recovery is running into significant headwinds, IHS Markit said The U.K.’s record- breaking debut green bond sale has given debt chief Robert Stheeman conviction on the benefits of an environmental borrowing program. The 10 billion-pound ($13.7 billion) deal this week was the biggest-ever ethical bond sale and the country is already planning another offering next month A more detailed look at global markets courtesy of Newsquaw Asian equity markets traded mostly positive as the region took its cue from the gains in US with the improved global sentiment spurred by some easing of Evergrande concerns and with stocks also unfazed by the marginally more hawkish than anticipated FOMC announcement (detailed above). ASX 200 (+1.0%) was underpinned by outperformance in the commodity-related sectors and strength in defensives, which have more than atoned for the losses in tech and financials, as well as helped markets overlook the record daily COVID-19 infections in Victoria state. Hang Seng (+0.7%) and Shanghai Comp. (+0.6%) were also positive after another respectable liquidity operation by the PBoC and with some relief in Evergrande shares which saw early gains of more than 30% after recent reports suggested a potential restructuring by China’s government and with the Co. Chairman noting that the top priority is to help wealth investors redeem their products, although the majority of the Evergrande gains were then pared and unit China Evergrande New Energy Vehicle fully retraced the initial double-digit advances. KOSPI (-0.5%) was the laggard as it played catch up to the recent losses on its first trading day of the week and amid concerns that COVID cases could surge following the holiday period, while Japanese markets were closed in observance of the Autumnal Equinox Day. China Pumps $17 Billion Into System Amid Evergrande Concerns China Stocks From Property to Tech Jump on Evergrande Respite Philippines Holds Key Rate to Spur Growth Amid Higher Prices Taiwan’s Trade Deal Application Sets Up Showdown With China Top Asian News European equities (Stoxx 600 +0.9%) trade on the front-foot and have extended gains since the cash open with the Stoxx 600 now higher on the week after Monday’s heavy losses. From a macro perspective, price action in Europe has been undeterred by a slowdown in Eurozone PMIs which saw the composite metric slip to 56.1 from 59.0 (exp. 58.5) with IHS Markit noting “an unwelcome combination of sharply slower economic growth and steeply rising prices.” Instead, stocks in the region have taken the cue from a firmer US and Asia-Pac handover with performance in Chinese markets aided by further liquidity injections by the PBoC. Some positivity has also been observed on the Evergrande front amid mounting expectations of a potential restructuring at the company. That said, at the time of writing, it remains unclear what the company’s intentions are for repaying its USD 83.5mln onshore coupon payment. Note, ING highlights that “missing that payment today would still leave a 30-day grace period before this is registered as a default”. The most recent reports via WSJ indicate that Chinese authorities are asking local governments to begin preparations for the potential downfall of Evergrande; however, the article highlights that this is a last resort and Beijing is reluctant to step in. Nonetheless, this article has taken the shine off the mornings risk appetite, though we do remain firmer on the session. Stateside, as the dust settles on yesterday’s FOMC announcement, futures are firmer with outperformance in the RTY (+0.8% vs. ES +0.7%). Sectors in Europe are higher across the board with outperformance in Tech and Autos with the latter aided by gains in Faurecia (+4.6%) who sit at the top of the Stoxx 600 after making an unsurprising cut to its guidance, which will at least provide some clarity on the Co.’s near-term future; in sympathy, Valeo (+6.6) is also a notable gainer in the region. To the downside, Entain (+2.6%) sit at the foot of the Stoxx 600 after recent strong gains with the latest newsflow surrounding the Co. noting that MGM Resorts is considering different methods to acquire control of the BetMGM online gambling business JV, following the DraftKings offer for Entain, according to sources. The agreement between Entain and MGM gives MGM the ability to block any deal with competing businesses; MGM officials believe this grants the leverage to take full control of BetMGM without spending much. Top European News BOE Confronts Rising Prices, Slower Growth: Decision Guide La Banque Postale Eyes Retail, Asset Management M&A in Europe Activist Bluebell Raises Pressure on Glaxo CEO Walmsley Norway Delivers Rate Lift-Off With Next Hike Set for December In FX, not much bang for the Buck even though the FOMC matched the most hawkish market expectations and Fed chair Powell arguably went further by concluding in the post-meeting press conference that substantial progress on the lagging labour front is all but done. Hence, assuming the economy remains on course, tapering could start as soon as November and be completed my the middle of 2022, though he continued to play down tightening prospects irrespective of the more hawkish trajectory implied by the latest SEP dot plots that are now skewed towards at least one hike next year and a cumulative seven over the forecast horizon. However, the Greenback only managed to grind out marginally higher highs overnight, with the index reaching 93.526 vs 93.517 at best yesterday before retreating quite sharply and quickly to 93.138 in advance of jobless claims and Markit’s flash PMIs. CAD/NZD/AUD - The Loonie is leading the comeback charge in major circles and only partially assisted by WTI keeping a firm bid mostly beyond Usd 72/brl, and Usd/Cad may remain contained within 1.2796-50 ahead of Canadian retail sales given decent option expiry interest nearby and protecting the downside (1 bn between 1.2650-65 and 2.7 bn from 1.2620-00). Meanwhile, the Kiwi has secured a firmer grip on the 0.7000 handle to test 0.7050 pre-NZ trade and the Aussie is looking much more comfortable beyond 0.7250 amidst signs of improvement in the flash PMIs, albeit with the services and composite headline indices still some way short of the 50.0 mark. NOK/GBP/EUR/CHF - All firmer, and the Norwegian Crown outperforming following confirmation of the start of rate normalisation by the Norges Bank that also underscored another 25 bp hike in December and further tightening via a loftier rate path. Eur/Nok encountered some support around 10.1000 for a while, but is now below, while the Pound has rebounded against the Dollar and Euro in the run up to the BoE at midday. Cable is back up around 1.3770 and Eur/Gbp circa 0.8580 as Eur/Usd hovers in the low 1.1700 area eyeing multiple and a couple of huge option expiries (at the 1.1700 strike in 4.1 bn, 1.1730 in 1 bn, 1.1745-55 totalling 2.7 bn and 1.8 bn from 1.1790-1.1800). Note, Eurozone and UK flash PMIs did not live up to their name, but hardly impacted. Elsewhere, the Franc is lagging either side of 0.9250 vs the Buck and 1.0835 against the Euro on the back of a dovish SNB Quarterly Review that retained a high Chf valuation and necessity to maintain NIRP, with only minor change in the ordering of the language surrounding intervention. JPY - The Yen is struggling to keep its head afloat of 110.00 vs the Greenback as Treasury yields rebound and risk sentiment remains bullish pre-Japanese CPI and in thinner trading conditions due to the Autumn Equinox holiday. In commodities, WTI and Brent have been choppy throughout the morning in-spite of the broadly constructive risk appetite. Benchmarks spent much of the morning in proximity to the unchanged mark but the most recent Evergrande developments, via WSJ, have dampened sentiment and sent WTI and Brent back into negative territory for the session and printing incremental fresh lows at the time of publication. Back to crude, newsflow has once again centred around energy ministry commentary with Iraq making clear that oil exports will continue to increase. Elsewhere, gas remains at the forefront of focus particularly in the UK/Europe but developments today have been somewhat incremental. On the subject, Citi writes that Asia and Europe Nat. Gas prices could reach USD 100/MMBtu of USD 580/BOE in the winter, under their tail-risk scenario. For metals, its very much a case of more of the same with base-metals supportive, albeit off-best given Evergrande, after a robust APAC session post-FOMC. Given the gas issues, desks highlight that some companies are being forced to suspend/reduce production of items such as steel in Asian/European markets, a narrative that could become pertinent for broader prices if the situation continues. Elsewhere, spot gold and silver are both modestly firmer but remain well within the range of yesterday’s session and are yet to recovery from the pressure seen in wake of the FOMC. US Event Calendar 8:30am: Sept. Initial Jobless Claims, est. 320,000, prior 332,000; Continuing Claims, est. 2.6m, prior 2.67m 8:30am: Aug. Chicago Fed Nat Activity Index, est. 0.50, prior 0.53 9:45am: Sept. Markit US Composite PMI, prior 55.4 9:45am: Sept. Markit US Services PMI, est. 54.9, prior 55.1 9:45am: Sept. Markit US Manufacturing PMI, est. 61.0, prior 61.1 11am: Sept. Kansas City Fed Manf. Activity, est. 25, prior 29 12pm: 2Q US Household Change in Net Wor, prior $5t DB's Jim Reid concludes the overnight wrap My wife was at a parents event at school last night so I had to read three lots of bedtime stories just as the Fed were announcing their policy decision. Peppa Pig, Biff and Kipper, and somebody called Wonder Kid were interspersed with Powell’s press conference live on my phone. It’s fair to say the kids weren’t that impressed by the dot plot and just wanted to join them up. The twins (just turned 4) got their first reading book homework this week and it was a bit sad that one of them was deemed ready to have one with words whereas the other one only pictures. The latter was very upset and cried that his brother had words and he didn’t. That should create even more competitive tension! Back to the dots and yesterday’s Fed meeting was on the hawkish side in terms of the dots and also in terms of Powell’s confidence that the taper could be complete by mid-2022. Powell said that the Fed could begin tapering bond purchases as soon as the November FOMC meeting, in line with our US economists’ forecasts. He left some room for uncertainty, saying they would taper only “If the economy continues to progress broadly in line with expectations, and also the overall situation is appropriate for this.” However he made clear that “the timing and pace of the coming reduction in asset purchases will not be intended to carry a direct signal regarding the timing of interest rate liftoff.” The quarterly “dot plot” showed that the 18 FOMC officials were split on whether to start raising rates next year or not. In June, the median dot indicated no rate increases until 2023, but now 6 members see a 25bps raise next year and 3 members see two such hikes. Their inflation forecasts were also revised up and DB’s Matt Luzzetti writes in his FOMC review (link here) that “If inflation is at or below the Fed's current forecast next year of 2.3% core PCE, liftoff is likely to come in 2023, consistent with our view. However, if inflation proves to be higher with inflation expectations continuing to rise, the first rate increase could well migrate into 2022.” Markets took the overall meeting very much in its stride with the biggest impact probably being a yield curve flattening even if US 10yr Treasury yields traded in just over a 4bp range yesterday and finishing -2.2bps lower at 1.301%. The 5y30y curve flattened -6.7bps to 95.6bps, its flattest level since August 2020, while the 2y10y curve was -4.2bps flatter. So the market seems to believe the more hawkish the Fed gets the more likely they’ll control inflation and/or choke the recovery. The puzzle is that even if the dots are correct, real Fed funds should still be negative and very accommodative historically for all of the forecasting period. As such the market has a very dim view of the ability of the economy to withstand rate hikes or alternatively that the QE technicals are overpowering everything at the moment. In equities, the S&P 500 was up nearly +1.0% 15 minutes prior to the Fed, and then rallied a further 0.5% in the immediate aftermath before a late dip look it back to +0.95%. The late dip meant that the S&P still has not seen a 1% up day since July 23. The index’s rise was driven by cyclicals in particular with energy (+3.17%), semiconductors (-2.20%), and banks (+2.13%) leading the way. Asian markets are mostly trading higher this morning with the Hang Seng (+0.69%), Shanghai Comp (+0.58%), ASX (+1.03%) and India’s Nifty (+0.81%) all up. The Kospi (-0.36%) is trading lower though and is still catching up from the early week holidays. Japan’s markets are closed for a holiday today. Futures on the S&P 500 are up +0.25% while those on the Stoxx 50 are up +0.49%. There is no new news on the Evergrande debt crisis however markets participants are likely to pay attention to whether the group is able to make interest rate payment on its 5 year dollar note today after the group had said yesterday that it resolved a domestic bond coupon by negotiations which was also due today. As we highlighted in our CoTD flash poll conducted earlier this week, market participants are not too worried about a wider fallout from the Evergrande crisis and even the Hang Seng Properties index is up +3.93% this morning and is largely back at the levels before the big Monday sell-off of -6.69%. Overnight we have received flash PMIs for Australia which improved as parts of the country have eased the coronavirus restrictions. The services reading came in at 44.9 (vs. 42.9 last month) and the manufacturing print was even stronger at 57.3 (vs. 52.0 last month). Japan’s flash PMIs will be out tomorrow due to today’s holiday. Ahead of the Fed, markets had continued to rebound from their declines earlier in the week, with Europe’s STOXX 600 gaining +0.99% to narrowly put the index in positive territory for the week. This continues the theme of a relative outperformance among European equities compared to the US, with the STOXX 600 having outpaced the S&P 500 for 5 consecutive sessions now, though obviously by a slim margin yesterday. Sovereign bonds in Europe also posted gains, with yields on 10yr bunds (-0.7bps), OATs (-1.0bps) and BTPs (-3.2bps) all moving lower. Furthermore, there was another tightening in peripheral spreads, with the gap in Italian 10yr yields over bunds falling to 98.8bps yesterday, less than half a basis point away from its tightest level since early April. Moving to fiscal and with Democrats seemingly unable to pass the $3.5 trillion Biden budget plan by Monday, when the House is set to vote on the bipartisan infrastructure bill, Republican leadership is calling on their members to vote against the bipartisan bill in hopes of delaying the process further. While the there is still a high likelihood the measure will eventually get passed, time is becoming a factor. Congress now has just over a week to get a government funding bill through both chambers of congress as well as raise the debt ceiling by next month. Republicans have told Democrats to do the latter in a partisan manner and include it in the reconciliation process which could mean that a significant portion of the Biden economic agenda – mostly encapsulated in the $3.5 trillion over 10 year budget – may have to be cut down to get the entire Democratic caucus on board. Looking ahead, an event to watch out for today will be the Bank of England’s policy decision at 12:00 London time, where our economists write (link here) that they expect no change in the policy settings. However, they do expect a reaffirmation of the BoE’s updated forward guidance that some tightening will be needed over the next few years to keep inflation in check, even if it’s too early to expect a further hawkish pivot at this stage. Staying on the UK, two further energy suppliers (Avro Energy and Green Supplier) ceased trading yesterday amidst the surge in gas prices, with the two supplying 2.9% of domestic customers between them. We have actually seen a modest fall in European natural gas prices over the last couple of days, with the benchmark future down -4.81% since its close on Monday, although it’s worth noting that still leaves them up +75.90% since the start of August alone. There wasn’t much data to speak of yesterday, though US existing home sales fell to an annualised rate of 5.88 in August (vs. 5.89m expected). Separately, the European Commission’s advance consumer confidence reading for the Euro Area unexpectedly rose to -4.0 in September (vs. -5.9 expected). To the day ahead now, the data highlights include the September flash PMIs from around the world, while in the US there’s the weekly initial jobless claims, the Chicago Fed’s national activity index for August, and the Kansas City fed’s manufacturing activity index for September. From central banks, there’ll be a monetary policy decision from the Bank of England, while the ECB will be publishing their Economic Bulletin and the ECB’s Elderson will also speak. From emerging markets, there’ll also be monetary policy decisions from the Central Bank of Turkey and the South African Reserve Bank. Finally in Germany, there’s an election debate with the lead candidates from the Bundestag parties. Tyler Durden Thu, 09/23/2021 - 08:13.....»»

Category: blogSource: zerohedgeSep 23rd, 2021

The top affiliate programs that influencers use to recommend products

The top creator economy news of the week includes an inside look at TikTok's workplace culture and the top affiliate-marketing programs. Tori Dunlap. Tori Dunlap Hi, this is Amanda Perelli and welcome back to Insider Influencers, our weekly rundown on the business of influencers, creators, and social-media platforms. Sign up for the newsletter here.In this week's edition:The top affiliate-marketing programs for influencersAn inside look at TikTok's six workplace principlesHow sliding into DMs can lead to a sponsorship dealMeet the chef who went from laid-off to TikTok starAnd more, including a breakdown of how much YouTubers earn a month for their videos and how a TikTok creator made over six figures from her e-commerce shopSend tips to aperelli@insider.com or DM me on Twitter at @arperelli. Rakuten Advertising; Share A Sale; LTK; MagicLinks; Samantha Lee/Insider The top affiliate-marketing programs for influencers Swipe ups, stickers, links in bio. We've all seen affiliate marketing at work.The commission-based model is one of the most straightforward and accessible ways that influencers can start earning money: share a trackable link to a product or service, and make a percentage of sales.Sydney Bradley and I highlighted the top affiliate-marketing networks used by influencers in 2021.Here's a look at a few of the programs that made the cut thanks to high commission rates, access to top brands, and robust interfaces and tools: The Amazon Influencer Program stands out for allowing creators to partner with the world's largest retailer and access a wide suite of tools. LTK (previously LIKEtoKNOW.it and rewardStyle) gives influencers a customized URL and an in-app page called an "LTK Shop," where they can compile a shopping list of their affiliate links for followers. MagicLinks offers the ability to conduct affiliate marketing through text message.Here's the full list of the top programs catering to influencers. TikTok; Samantha Lee/Insider Inside TikTok: How ByteDance's culture principles are used to reward and reprimandEvery tech startup has its own culture, and we got an inside look at TikTok's. Employees at the video app must abide by a set of six workplace principles - dubbed "ByteStyles" - written by its parent company ByteDance.The company rules are often fairly broad, like "be grounded and courageous" and "be open and humble." Internally, staffers use ByteStyles as a way to call out what the company deems good or bad performance during employee evaluations, my colleague Dan Whateley wrote.While adhering to ByteStyles can lead to gifts or awards, not following the cultural tenets can lead to discipline.Their open-ended nature can be frustrating when applied to specific work situations, according to four current and former TikTok employees. Sometimes ByteStyles are used as catch-all warnings to employees about behavior that the company didn't like."'That's not ByteStyles!' is like so general, but thrown around [when] anyone kind of does stuff the other person doesn't like," a current TikTok employee told Insider.Read more about the principles and how they impact TikTok's culture.Here's what else you need to know this week:What's trending We tried a personal training session at Dogpound LA - where TikTok stars Addison Rae, Josh Richards, and Bryce Hall sweat it out.A 40-year-old lipstick is selling out after it became TikTok's latest obsession.TikTok is turning decade-old books into bestsellers.Creator earnings An inside look at the media kits of YouTube, Instagram, and TikTok stars.YouTube stars break down how much they make per month on the platform. How TikTok helped a cotton candy maker earn $165,000 in sales in six months.Marketing movesInfluencer agency Digital Brand Architects hired Ernest B. James as SVP of special projects.Snap has made three new hires on the talent partnerships team: Julie Bogaert, Racquel Douglas, and Emily McDonnell.ICM agent Chris Sawtelle is leaving the firm to become co-president of TikTok star Josh Richards' CrossCheck Holdings. Tori Dunlap. Tori Dunlap Read the Instagram DM templates one influencer uses to land brand dealsPersonal-finance influencer Tori Dunlap has 1.7 million TikTok followers and earns thousands of dollars promoting companies like Credit Karma and Four Seasons.Her tip for scoring those brand deals? Slide into the DMs. She landed her first paid deal last year after reaching out to Personal Capital, a personal wealth management company, over Instagram DM.I spoke with Dunlap who shared templates for other influencers to use and said not to fear rejection."Just because they said no now, doesn't mean that's no forever. I have 2 million followers and I still get 'no' a lot," Dunlap, who is 26, told Insider.Check out the exact DM templates Dunlap uses to score paid deals, here. Poppy O'Toole trained in a Michelin-starred kitchen before pivoting to become a social media chef. Louise Hagger How a chef went from laid-off to TikTok starFor Insider's as-told-to essay series, 27-year-old Michelin-trained chef Poppy O'Toole shared how she became a social-media creator. She started filming TikToks of easy-to-follow recipes during the first UK lockdown in March 2020, after she'd been let go from her job as a chef in London.Now, she says she's surpassed her old salary and has a cookbook in the works.Read her essay on how TikTok turned her career around.Chart of the week: The Influencer Marketing Factory released a creator economy report, with insights from executives at Patreon, Koji, and Jellysmack. In the chart above, influencers share which platform is the most lucrative.Check out the full report here. Screen shot of #plantbased on TikTok TikTok hashtag of the week: Every week, we highlight a top trending hashtag on TikTok, according to data provided by Kyra IQ.This week's hashtag: #plantbasedPercentage uptick over the last 7 days: 8,520%The latest viral hashtag is centered around popular plant-based recipes, like a recreation of Gordon Ramsay's vegan bacon recipe, which is made with tofu and has 1.2 million views. Theo Wargo/Getty Images What else we're reading and watching:Disney is looking to create breakout TikTok and Instagram stars (Garett Sloane, from Ad Age)The Met Gala invited nearly double the amount of content creators this year (Alexa Tietjen, from WWD)Creators Colin and Samir uploaded a 2-hour interview with YouTube star MrBeast. Watch here.Subscribe to the newsletter here.And before you go, check out the top trending songs on TikTok this week to add to your playlist. The data was collected by UTA IQ, the research, analytics, and digital strategy division of United Talent Agency. UTA IQ Subscribe to the newsletter here.Read the original article on Business Insider.....»»

Category: topSource: businessinsiderSep 23rd, 2021

Time To Say Goodbye To The Everything Bubble

Time To Say Goodbye To The Everything Bubble Authored by Egon von Greyerz via GoldSwitzerland.com, Will the autumn of 2021 be the end of the everything bubble? Are investment markets very soon coming to the end of market insanity? Since there is very little sanity left in markets or the in the world economy, we have now reached a point where we must accept madness as sanity, as George Bernard Shaw said: “When the world goes mad, one must accept madness as sanity; since sanity is, in the last analysis, nothing but the madness on which the whole world happens to agree.” George Bernard Shaw Investment markets today are all about instant gratification and getting rich quick. “Stocks always go up” and so does property in the everything bubble. Even the normally boring bond market has had a 40 year rise. And then we have the supercharged tech stocks, many of which have gained 1000s of percent in this century And we mustn’t forget the SPAC stocks (Special Purpose Acquisition Companies) or Blank Cheque Companies where shell companies are used to acquire existing companies to inflate their share price. None of these things are new of course. During the South Sea Bubble in the 1720s for example, companies were formed and capital raised with just the purpose of “Making Money”. We mustn’t forget the cryptocurrencies which are now worth valued at $2 trillion. They were just over $1 billion 8 years ago. Is that the bubble of the century like tulip bulbs in the 1600s or is it the money of the future. Well, most readers know or can guess my opinion on this! VALUE INVESTING & WEALTH PRESERVATION IS FOR “WIMPS” In a world where everything is based on “get rich quick” neither value investing nor wealth preservation enters the equation. Why worry about preserving your wealth when you could have made 14x your money on the Nasdaq since 2009 or 5,000x your investment on Bitcoin since 2011. Calling tops is a mug’s game. Some of us who look at risk have been worried about the everything bubble economy for quite a while. To us, since the end of the Great Financial Crisis in 2009, the world economy and asset markets have been an illusion. It is as if we are watching a virtual reality game in which some people automatically increase their wealth by millions or even billions of dollars every time they pass GO. But as the rich are getting richer, the masses are just getting poorer and more indebted. Although we see the wealth that has been acquired by many as an illusion that will soon evaporate, for the ones who have benefited, this is all very real. Anyone who believes that these gains are real and sustainable will have the shock of a lifetime in coming years. As I showed in a recent article about the End of the US Empire, the wealth of the 400 richest Americans has gone from 2% of GDP to 18% in the last 40 years. This concentration of wealth is of course spectacular but also very dangerous for the world. Trees can always grow taller but they never grow to heaven! AT THE END OF AN ERA – FALLS OF 90% So as Shaw said, we are now in “the madness on which the whole world agrees”. As I have often stated, I believe that we are at the end of a very major economic cycle. Not only are markets insane, but so are deficits, debts and currency debasements. But also moral and ethical values have now vanished into thin air and been replaced by lies, deceit and the golden calf. We are now in a very critical period for the world since excesses of the magnitude we are now seeing must be corrected. Exponential moves in one direction are always corrected. And the corrections will be of a similar magnitude to the rise but happen much quicker. We are talking about falls of 90% or more in all major asset and debt markets. Nobody believes such moves are possible with central banks and governments standing by with unlimited money printing combined with new Central Bank Digital Currencies that will save the world. ILLUSIONS ARE JUST ILLUSIONS We must understand that illusions cannot rescue the world economy.  This despite whatever concoctions central banks or Schwab (World Economic Forum) and his billionaire cronies come up with. Virtual illusions in the form of fake money or empty promises can never repay debt, nor can they change the laws of nature. Clearly all these “evil forces” will use their power to orchestrate fake resets to “save the world” in an attempt to tighten their grip on the world economy and the financial system. But a heavily indebted and fake system can never be reset in an orderly manner. In my view, any artificial or fake reset will only have a very limited effect. It is just not possible to solve a debt problem with more debt whatever way the PTB (Powers That Be) try to dress it in sheep’s clothing. So an orderly reset is bound to fail very quickly. A new digital Fiat and thus fake currency will not solve the world’s debt problem. Writing off the debt is just another illusory act. If you write off the debt, the assets on the opposite side of the balance sheet will also implode in value. And since the debt is leveraging the assets, they will have a very long way to fall. This is why asset implosions of 90-100% are very likely. Few people believe this to be possible but with debt collapsing so will the bubble assets which are all inflated by worthless debt. We must remember that the big stock market crash in 1929-32 saw the Dow lose 90% of its value. It then took 25 years for the Dow to get above the 1929 high. And today 92 years after that peak, debts, deficits, and asset bubbles are far greater than at the end of the 1920s. Below are a number of graphs that all point to the everything bubble. THE BUFFETT INDICATOR So there we have it, incontrovertible proof that this is the mother of all bubbles. But as we have learnt in this century, bubbles can always grow bigger and especially if we are looking at the end of a major super cycle which could be as big (or long) as 2,000 years. Nevertheless, the evidence keeps mounting of an epic asset bubble. In addition to the charts above that point to illusions never seen before in markets, we have a number of technical indicators that all point to the end of the everything bubble. In the chart below, the RSI (Relative Strength Index) momentum indicator for example topped in 2017 and the major rise in the Dow since then has not been confirmed by the indicator. This is a very bearish sign albeit not a short term indicator. Many other technical indicators including Elliott wave or Dow Theory all point to that a top to the everything bubble is imminent. Whether that means a top next week (which is possible), or in the next few months, time will tell. Some important cycle indicators point to potential turns between now and Sep 24. SURVIVING THE EVERYTHING BUBBLE IS ALL ABOUT PROTECTING FROM RISK But what is much more important than pinpointing the exact timing of the top is to understand the risk involved. If, as we believe, we are now at the end of the everything bubble, nobody needs to time it. Investors should understand the upside might be 10% and the downside 90%+. Who is foolish enough to accept such a risk? Maybe a 10% move up but a more certain 90% fall. We are talking about a fall in real terms. If we get hyperinflation stocks and other assets can rise in nominal terms but fall in real terms when measured in stable purchasing power, like gold. Well, that question is easy to answer. The whole investment world which has been spoilt by tens of trillions of dollars of fake money to fuel the Epic Everything Bubble will expect much more of the same in coming months or years. Yes, much more money will be created but this time it will have very little effect. Instead the dollar, euro, yen etc will accelerate the falls that we have seen since 1913. They have all fallen 98-99% since then and by similar percentages since 1971 when Nixon closed the gold window. The final 1-2% fall will soon start and take most currencies to their intrinsic value of ZERO. But don’t forget that this final fall is 100% from here. Remember that measuring your assets in for example dollars is a futile exercise in self indulgence. You are just flattering your investment skills when you measure your performance in a currency that has lost 98% since 1971 and 84% since 2000. If you use the same method in coming years, your paper wealth might look ok but be worthless in real terms. Just ask anyone who has lived in a hyperinflationary economy like Yugoslavia, Argentina or Venezuela.  So what is a Sleeping Beauty investment. Not difficult to guess. It is an investment that you can forget about for 100 years and when you wake up, it will have maintained its purchasing power. GOLD If we get the expected stock market crash, it is possible that gold and the precious metals continue to correct a bit further like in 2008. As opposed to today, gold had then had a major bull run from $250 in 1999 to $1,000 in 2008. Weak gold hands then needed to get liquidity against a crashing stock market and the everything bubble. Gold has now been in consolidation for years and there are a lot fewer speculative  investors compared to 2008. Therefore I expect a much smaller and shorter correction, if any. Coming back to the Sleeping Beauty, there is one investment which you could safely put away and forget about for 100 years. It is of course physical gold, safely stored. As long as you store gold in a safe place and safe country, you know that it will maintain  its REAL value as it has for 5,000 years.  Yes, there are fluctuations, but gold’s history tells us that it is not just the only money which has survived but also the only money which has maintained real purchasing power.  Gold today at $1,750 is as UNLOVED AND UNDERVALUED as in 1971 at $35 and in 2000 at $288.  I will continue to show the chart below until that situation is rectified. This reminds me of the Roman Senator Cato during the Punic Wars (around 150 BC) who finished every speech in the senate with “Furthermore I consider that Carthage must be destroyed”. In the end Cato got his way as Carthage was destroyed. I have no doubt that gold will soon rectify the current undervaluation and reach levels that few can imagine. This is what both technicals and fundamentals are clearly indicating. Tyler Durden Thu, 09/23/2021 - 06:30.....»»

Category: blogSource: zerohedgeSep 23rd, 2021